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Abstract 
 
The past two decades have highlighted the utility in using the fruit fly 
Drosophila as a model organism for unravelling the molecular and functional 
complexities of two important fields of research: the systems that guide retinal 
determination (RD) and circadian rhythms (the daily body clock or oscillator). RD 
and clock factors are of great interest as they are: (1) highly conserved in 
vertebrates; (2) also essential for other physiological systems; (3) implicated in 
several congenital disorders and other diseases. 
 
The RD factors operate within a network in which several of their interactions 
have been described. Two such factors, eyes absent (eya) and sine oculis (so), 
are known to function as a unit to direct transcriptional regulation during 
photoreceptor (PR) differentiation. The regulation of eya and so by a 
transcriptional repressor at the heart of the clock mechanism, vrille (vri), is 
here investigated. Two distinct observations advocated exploration of a link 
between vri and eya/ so is of interest. (1) vri is a core component of the clock 
and interacts with RD but the RD function is unknown. (2) Recent evidence 
suggests that an RD factor directly upstream of eya and so, twin-of-eyeless 
(toy), interacts with the oscillator mechanism through direct and indirect 
pathways. It is possible that the indirect influences of toy on the oscillator are 
mediated via eya and/ or so. Interactions between eya, so and vri during RD and 
within oscillator cells are investigated here. 
 
Eye development function was studied using immunohistochemistry and 
transgenic manipulation. VRI is not expressed within the developed PRs; rather, 
expression of VRI is down-regulated prior to differentiation. In addition, 
conversely to the hypothesised role, VRI is co-expressed with EYA in some 
regions. Together with data from transgenic manipulation of VRI regional 
expression, I propose that VRI is predominantly part of a developmental pathway 
but can attenuate eya and so expression. 
 
The VRI binding site has been described previously and several sites were 
identified within eya/ so loci, some of which were tested in an in vitro binding 
assay. Two such sites were located adjacent to a known enhancer of so. I 
generated two transgenic fly lines containing: 1) an extension of the original 
enhancer to contain the VRI sites; and 2) a similar construct with the VRI sites 
ablated. Comparison of the original enhancer to those from the current study 
confirmed that the VRI sites attenuate expression and that intervening regions 
must contain binding sites for other transcription factors. 
 
In adult brains over a circadian light-dark cycle, EYA protein was expressed in 
three of the central brain clock neurones. Furthermore, expression of eya and so 
transcripts in adult heads, PRs and the brain, changed over the light/ dark cycle 
independently of the clock – indicating that their expression is modulated over 
the light-dark cycle but not by the oscillator mechanism. 
 
These data suggest interactions between eye development factors eya/ so and 
oscillator components, or, the light/ dark cycle exist. These interactions may be 
important for tissue-specific circadian physiology as well as the overall oscillator 
mechanism and offer an intriguing route for future investigation. 
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Chapter 1 General introduction 
 
Two areas that have been extensively researched in the fruit fly Drosophila 
melanogaster are development and the maintenance of circadian rhythms: 
both of which show striking parallels in mice and humans. The study of 
development is of interest because of the many areas in biology that are 
involved in this process, for example, apoptotic mechanisms; cell-cell 
interactions; signal transduction; transcriptional regulation; congenital 
disorders; stem cell biology; and evolution. Many upstream components that 
regulate development are highly conserved across phyla and help us to 
understand the evolution of inter- and intra-cellular interactions. Moreover, 
some factors that are involved in the development of an organism can also be 
employed in later, non-developmental stages, so, understanding the role they 
play during development can inform about mechanisms in the mature system. 
 
Chronobiology – the study of behavioural, molecular and physiological cycles – 
is attractive as it shows a high level of functional conservation. The ability to 
anticipate, co-ordinate and adapt behavioural, metabolic and physiological 
functions to environmental changes imparts a significant survival advantage. 
Biorhythms may be linked to a variety of environmental changes, however, 
the influence of the daily light-dark cycle is most extensively researched. 
Indeed, evidence for the importance of daily biorhythms lies in several 
established links between disruption of daily rhythms and pathophysiology 
ranging from cell proliferation (Reddy et al., 2005); cardiac function (Durgan 
and Young, 2010); neurodegeneration (Bao et al., 2008); to pharmacokinetics 
(Lévi et al., 2008), to name a few.  
 
Daily oscillations may be studied on a whole animal behavioural level, optimal 
function of an organ or, at the molecular level. The molecular oscillator 
mechanism comprises a set of factors that show rhythmic changes in gene 
transcription and protein turnover and form a feedback regulatory network. 
Moreover, the molecular oscillator has been observed in several different cell 
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types – neurones within the central nervous system (CNS) that influence 
behaviour and in cells comprising organs that show daily changes in function. 
Currently, there is a lack of data about the molecular oscillator and how it 
interacts with tissue-specific factors within cells of a given organ to mediate 
physiological changes that are linked to the light-dark cycle. The compound 
eyes of the fruit fly are formed of approximately eight hundred individual 
photoreceptive units, or ommatidia (Voas et al., 2004). All eight 
photoreceptors (PRs, R1-R8) within each ommatidium and the PRs of the 
ocelli, simple eyes located medially on dorsal head, contain cell-autonomous 
oscillators (Cheng and Hardin, 1998). The PRs thus comprise the largest 
tissue-specific oscillators of the adult fly head and were used here to begin 
exploring links between retinal determination factors and the oscillator 
mechanism. I will set the scene for these studies by outlining the relevant 
aspects of eye development and circadian rhythms of Drosophila 
melanogaster. 
 
1.1 Eye development 
 
Development of the adult visual systems, the compound eye and the ocelli, of 
Drosophila is initiated during embryonic development, remains dormant 
during early larval stages and resumes from late larval stages until emergence 
of the adult (Cohen, 1993; Poulson, 1994). Many of the key factors involved in 
eye development have been identified and found to interact within a 
feedback network rather than a binary cascade (reviewed in Kumar, 2009b). 
The factors that form this network may be split into two categories: (1) the 
retinal determination gene network (RDGN) factors; so described because of 
eye-specific mutant phenotypes and the ability to trans-determine tissue of 
other imaginal discs towards an eye fate when ectopically expressed. (2) 
developmental regulatory (DR) factors of signalling cascades that have 
pleiotropic roles throughout development in a multitude of tissues. Co-
ordination between the RDGN and the DR factors is required for generation of 
the reiteratively patterned retina. Here, I am going to focus on the activation 
of two of the RDGN factors, eyes absent (eya) and sine oculis (so). During eye 
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development, eya and so expression is completely overlapping. In addition, 
the proteins dimerise to form a transactivation complex (Pignoni et al., 1997). 
As a result of this close relationship, eya and so are frequently studied in 
conjunction and here also, referred to with reference to one another. 
 
A cluster of fourteen cells at the posterior ventral part of this optic placode 
form the precursors of the larval visual system called Bolwig’s organ (BO, 
Suzuki and Saigo, 2000). The cells first adopt a neural fate and then begin to 
develop a PR identity. The BO innervates the region containing a subset of the 
larval central brain circadian neurones to entrain those neurones to the light-
dark cycle throughout larval development (Malpel et al., 2002). During pupal 
development, the B-O PRs and projections are retained in this functional 
capacity but are now known as part of an extra-retinal structure called the 
Hofbauer-Buchner (H-B) eyelet (Helfrich-Förster et al., 2002). The current 
study focuses on the development of the compound eye PRs as they also have 
intrinsic oscillator function whereas the H-B eyelet PRs do not. However, the 
PRs of the eyelet, together with the compound eye and ocellar PRs and a non-
opsin, blue light molecular photoreceptor all contribute to the entrainment of 
the central brain circadian neurones in the adult fly (Helfrich-Förster et al., 
2001; Helfrich-Förster et al., 2002). 
 
1.1.1 Specification and early development 
 
The adult visual system primordia arise as two bilaterally symmetrical groups 
of epithelial cells that meet at the dorsal midline to form a V-shape in the 
procephalic region (Cohen, 1993). Following patterning and organisation of 
the germ layers, regions of the epithelium dedicated to make any of the adult 
organs begin to invaginate to form flattened sacs of tissue known as imaginal 
discs (imaginal = of the imago, imago = adult; Campos-Ortega and 
Hartenstein, 1985). The eye imaginal disc is fused to the antennal imaginal 
disc and indeed they have a common origin, being specified by the same 
factors, and are indistinguishable at the molecular level until later stages 
(Kumar and Moses, 2001a). Following invagination, the discs do not develop 
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further until larval stages. The two Pax-6 genes, twin of eyeless (toy) and 
eyeless (ey), are expressed from the embryonic origin of the eye disc and 
persist through to adult stages; both are RDGN components (Quiring et al., 
1994; Czerny et al., 1999; Halder et al., 1995; Pappu and Mardon, 2002). 
 
The larva goes through three distinct developmental stages known as instars 
(Bodenstein, 1994), where progression from one larval instar to the next 
involves shedding of the cuticle. Successive larval stages are larger and have 
more developed and readily identifiable mouthparts; hereafter referred to as 
L1, L2 and L3. Throughout L1, L2 and early L3 larval development, larvae are 
devoted to feeding. This behaviour changes near the end of L3 – where larvae 
emerge from the food and begin ‘wandering’, or crawling to find a place to 
settle for puapariation. This behaviour coincides with developmental changes 
occurring within the eye disc. 
 
During L1 to mid-L2 stages, discs grow by cell proliferation but development 
of eye identity remains dormant (Czerny et al., 1999; Kammermeier et al., 
2001). Eye or antennal identity is acquired later, during the mid- to late-L2 
stage, by the antagonistic action of two DR factors (see Table 1.1; Kumar and 
Moses, 2001a). 
 
1.1.2 Determination and differentiation of photoreceptors 
 
The major regulatory interactions that initiate eye precursor cell 
differentiation with reference to eya and so are summarised in Figure 1.1, an 
extended overview of interactions is listed in Table 1.1. The development of 
the disc into an eye begins during mid- to late-L3 and appears as a wave of 
differentiation, termed the morphogenetic furrow (MF), on the apical surface 
of the disc that moves as a DV-oriented line across the disc from posterior to 
anterior (Wolff and Donald, 1993). As the MF passes across the disc, hexagonal 
arrays of cells develop posterior to it and reflect the shape of the adult 
ommatidia. These cell arrays comprise the eight post-mitotic PR neurones 
that have terminally differentiated. 
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Figure 1.1 A schematic of the L3 eye disc. (A) The layout of the eye antennal disc during late L3. (B) 
Enlarged eye disc from (A); some retinal determination genes and MF-associated factors are shown 
together with their interactions. Solid blue arrows indicate direct, known transcriptional activation 
between retinal determination genes; purple box indicates EYA-SO complex; dashed blue arrows show 
predicted activation by DAC; dashed orange line with bar shows predicted inhibition by DAC; dotted 
lines show regulation by morphogens where the exact pathway has not been characterised: dotted green 
arrows show positive regulation, dotted orange lines with bars show negative regulation. (C) Adapted 
and expanded from Bessa et al. (2002), dotted lines outline zones of the eye disc. Shaded areas show 
the expression domains of the molecules indicated on the right. MF, morphogenetic furrow; PPN, pre-
proneural zone; refer to text for further gene information (Czerny et al., 1999; Halder et al., 1995; 
Pappu and Mardon, 2002; Chen et al., 1997; Halder et al., 1998; Baonza and Freeman, 2002; Chen et 
al., 1999; Pignoni et al., 1997; Bonini et al., 1993; Bonini et al., 1997; Punzo et al., 2002; Chanut and 
Heberlein, 1997; Bessa et al., 2002). 
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Table 1.1 Summary of the roles of core eye determination factors and developmental 
regulators closely linked to eye determination. See Figure 1.1 for information about 
expression zones of the L3 eye disc; TF – transcription factor. (Bessa et al., 2002; Kumar and 
Moses, 2001a-c; Pignoni et al., 1997; Halder et al., 1998; Chen et al., 1999; Curtiss and 
Mlodzik, 2000; Pappu et al., 2003; Baonza and Freeman, 2002; Czerny et al., 1999; Punzo et 
al., 2001; Pauli et al., 2005; Pappu et al., 2005; Chanut and Heberlein, 1997; Chen et al., 
1997; Kenyon et al., 2005; Seimiya and Gehring, 2000; Ostrin et al., 2006; Mardon et al., 
1994; Salzer et al., 2009) 
Gene Category, 
protein type 
Role during eye development 
twin of eyeless 
(toy) 
RDGN, Pax6 Expressed from eye primordium stage 
and in anterior eye disc zones II and 
PPN, down-regulated as MF advances. 
Activates ey initially; subsequently eya 
(inferred by homology with ey) and so. 
eyeless (ey) RDGN, Pax6 Expressed from eye primordium stage 
and in anterior eye disc zones II and 
PPN, down-regulated as MF advances. 
Activates toy, eya, so and optix; is 
activated by EYA-SO 
eyes absent 
(eya) 
RDGN, Eya Expressed in eye disc zones PPN, MF and 
IV. Complexes with SO and/ or DAC to 
activate gene expression of so, ey, dac 
(anterior of zone IV only), hh, string, 
lozenge and atonal. 
sine oculis (so) RDGN, Six Expressed in eye disc zones PPN, MF and 
IV. Complexes with EYA and/ or DAC to 
activate gene expression of so, ey, dac 
(anterior of zone IV only), hh, string, 
lozenge and atonal. Can dimerise with 
GROUCHO to repress dac in posterior of 
zone IV. 
dachshund (dac) RDGN, Ski/Sno Expressed in eye disc zones PPN, MF and 
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anterior of IV. Complex and unresolved 
role, may form dimers with EYA or SO, 
and/ or form a trimeric DAC-SO-EYA 
complex. 
optix RDGN, Six Expressed in anterior eye disc zones II 
and PPN. Closely related to SO, partners 
with a transcriptional co-repressor, 
GROUCHO. 
teashirt (tsh) RDGN, zinc 
finger TF 
Expressed in anterior eye disc zones II 
and PPN. Context-dependent role – 
together with HTH, EY and WG, 
repression of eya and dac in anterior eye 
disc distal to MF; together with EY, 
promotion of eya and dac proximal to 
MF. 
homothorax 
(hth) 
RDGN, 
homeobox 
Expressed in ventral eye primordium and 
in anterior eye disc zones I and II. 
Suppression of eye specification in the 
ventral region of the eye primordium 
and anterior eye disc, inhibition of MF 
initiation; co-regulation with TSH, EY 
and WG. 
hedgehog (hh) DR, secreted 
morphogen 
Expressed at posterior eye disc zone IV 
and lateral margins of the eye disc, 
together with DPP promotes MF 
initiation and propagation. 
Notch (N) DR, signal 
transduction 
Pleiotropic roles during eye 
development, usually antagonistic to 
EGFR: initial promotion of eye identity; 
lateral inhibition for PR differentiation. 
Not antagonistic but integrated with 
EGFR upstream of dpp and hh for MF 
initiation. 
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epidermal 
growth factor 
receptor (EGFR) 
DR, signal 
transduction 
Pleiotropic roles during eye 
development, usually antagonistic to 
Notch: initial promotion of antennal 
identity. Not antagonistic but integrated 
with Notch upstream of dpp and hh for 
MF initiation. Involved in cell identity 
specification. 
decapentaplegic 
(dpp) 
DR, secreted 
morphogen of 
the TGF"/ BMP 
family 
Expressed in MF and lateral margins of 
the eye disc, together with HH promotes 
MF initiation and propagation. 
wingless (wg) DR, secreted 
morphogen 
Expressed in anterior eye disc zones I 
and II, antagonises role of DPP. 
 
TOY and EY, are referred to as the ‘master’ eye regulators and activate RDGN 
genes eya and so (Pappu and Mardon, 2002; Kumar, 2009b). Mutants of these 
genes show severe eye defects (i.e. reduced or absent eyes) as each is 
absolutely required for normal eye development and ectopic expression in 
other imaginal discs can lead to ectopic eye development (Halder et al., 
1995; Pappu and Mardon, 2002). In the anterior eye disc, within zones II and 
PPN, TOY and EY are expressed at a high level but are down-regulated within 
the MF and zone IV (Halder et al., 1998; Czerny et al., 1999, Jemc and Rebay, 
2007a). During L2, eya and so are expressed in the eye disc but during L3, 
their expression is restricted zones PPN, MF and IV (Bonini et al., 1993; 
Cheyette et al., 1994; Pignoni et al., 1997; Bonini et al., 1997; Jemc and 
Rebay, 2007a). 
 
TOY initially activates ey expression and TOY and EY then co-activate eya and 
so, and another RDGN factor dachshund (dac); EYA and SO dimerise to form 
the EYA-SO complex and can also interact with DAC individually and within a 
trimeric complex to drive retinal determination (Czerny et al., 1999; Chen et 
al., 1997; Halder et al., 1998; Pignoni et al., 1997; Bonini et al., 1997; Punzo 
et al., 2002; Hauck et al., 1999). Among EYA-SO targets, positive feedback 
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that reinforces the network has been observed by activation of ey, dac 
(anterior zone IV only, see Figure 1.1) and auto-regulation of so itself (Pignoni 
et al., 1997; Pauli et al., 2005). The retinal determination targets of EYA-SO 
include the proneural gene atonal; the cell cycle regulator string; the cell 
fate determinant lozenge; and, hedgehog (hh), a secreted morphogen and a 
DR factor of eye development (see Table 1.1 for hh; Yan et al., 2003; Pauli et 
al., 2005; Zhang et al., 2006; Jemc and Rebay, 2007). Regulation of dac 
changes dependent on the position of the cells. Activation by EYA-SO is only in 
the anterior of zone IV; in the posterior of zone IV, SO dimerises with the co-
repressor GROUCHO to suppress dac expression. 
 
1.1.3 Additional details of selected retinal development 
factors 
 
1.1.3.1 TOY and EY 
The Pax family of developmental regulators are highly conserved and contain 
a DNA-binding domain called a paired box; and several members also contain 
a homeobox (reviewed in Dahl et al., 1997; Blake et al., 2008). Pax factors all 
appear to be key embryonic regulators that are essential for the specification 
of CNS and other organs. Pax-6 genes specify eye and other CNS regions in 
Drosophila (toy or ey), mouse, or human homologues (Czerny et al., 1999; 
Punzo et al., 2001; Kozmik, 2005). Viable mutations in the mouse and human 
homologues of Pax-6 genes can cause a range of defects from mild anomalies 
to serious defects in the CNS; loss of eye; loss of olfaction; or loss of the 
external nasal structures (Hanson, 2001). Null mutants of toy or ey are 
embryonic lethal and the only viable mutants of toy and ey are eye-specific. 
The presence of two Pax-6 genes in Drosophila arose due to a local 
duplication event as only a single orthologue of Pax-6 is found in vertebrates 
though the homologues remain closely related (Czerny et al., 1999). The 
homeodomain of both TOY and EY shares 90% sequence identity with 
vertebrate PAX-6 proteins, while the paired domain shows 91% (TOY) and 95% 
(EY) identity to vertebrate PAX-6. Despite their close relationship, only partial 
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co-expression is observed during embryonic development and, together with 
eyeless phenotypes of single mutants, indicates that they do not serve 
redundant functions to one another. 
 
During larval and adult stages, toy and ey expression is evident in regions of 
the brain, ventral nerve cord (VNC) and eye tissue. The optic lobes and 
central brain, in particular the olfactory processing centres, show toy and ey 
signals that partially overlap. Whilst both are highly expressed in the olfactory 
centres, toy is expressed more broadly than ey. 
 
Some of the spatial expression of toy within the central brain is now being 
resolved (Glossop et al., unpublished results). Links to a subset of oscillator 
neurones of the central brain are indicated, this is discussed further in section 
1.3. 
 
1.1.3.2 EYA and SO 
Throughout embryonic development, eya and so are expressed in the head 
and in a segmentally reiterated pattern within the ventral nerve cord (EYA 
and DAC, so data from lacZ enhancer trap; Kumar and Moses, 2001c). Optic 
lobe primordia, but not the embryonic anlagen of the eye disc, express eya 
and so – suggesting a function in CNS patterning at this stage of development 
(Bonini et al., 1998; Halder et al., 1998; Kumar and Moses, 2001c). 
Accordingly, null mutants of either of these genes causes lethality and the 
early mutants that were recovered, that defined the names of these genes, 
consisted of alleles containing deletions of eye-specific enhancers. Due to the 
availability of viable mutants of the eye phenotype and extensive data on eye 
development, research has been focused on the eye disc and there is little 
data about the other roles of eya and so during development or in the mature 
system. Non-ocular roles for eya and so are better described in vertebrates 
and indicate that mis-regulation of Eya or Six factors is tumorigenic (Jemc and 
Rebay, 2007a). In addition, it was recently shown that Eya3 and Six1 interact 
and form part of a pituitary endocrine response to photoperiod (Masumoto et 
al., 2010; Dardente et al., 2010). 
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The EYA protein has dual functions – transcriptional regulation (in conjunction 
with SO) and tyrosine phosphatase activity (reviewed in Jemc and Rebay, 
2007a). A single eya gene is found in Drosophila whereas four homologues, 
Eya1-4, are present in mice and humans. Homologues of eya have also been 
implicated in development and disease in vertebrates. Pathologies observed 
in mice and humans include vision deficits, hearing defects, loss of the ears, 
branchial arch abnormalities and kidney defects (reviewed in Hanson, 2001). 
Expression of Eya homologues is thus essential for organogenesis in other 
tissues besides the eyes but it remains possible that there is partial 
compensation or redundancy. In eye development, Eya1-3 has been observed 
in the mammalian eye but a myriad of Eya1 phenotypes suggest that Eya2 and 
Eya3 can partially compensate for the loss of Eya1. 
 
The Six gene family was founded by so and contains a homeobox DNA binding 
domain and the protein interaction six domain (reviewed in Kumar, 2009a). 
Two additional orthologues of so are present in Drosophila, optix and D-six4. 
Of these, optix is known as an RDGN factor that is expressed in anterior 
regions of the disc whereas D-six4 functions in mesoderm-derived cells of the 
muscles, fat body and somatic gonadal cells. All three of these genes are 
conserved in vertebrates and appear to have duplicated to form three distinct 
gene families with two members in each. However, optix and D-six4 
homologues are expressed within the developing vertebrate eyes while so 
homologues are more restricted to the nasal and otic placodes, branchial 
arches, the kidney, craniofacial muscles and other muscular, skeletal and 
connective tissues. Pathologies involving Six family members are similar to 
those observed for Eya1-4, unsurprising given that factors of the Eya and Six 
families are expressed in similar tissues (Hanson, 2001; Kumar, 2009a). 
 
1.1.3.3 A circadian regulator helps shape the eye 
The basic leucine zipper (bZip) transcriptional factor vrille (vri) is a 
developmental regulator and, as mentioned about toy, ey, eya and so, is 
essential from embryonic stages as null or homozygous mutants are embryonic 
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lethal (George and Terracol, 1997). Mutant alleles are only recovered when 
enhancer/ promoter regions are disrupted and only in trans to wild-type or 
other mutant alleles. Several stages and tissues of the embryo require vri, 
and of particular relevance here, proliferating tissues, i.e. the imaginal 
epithelia of discs and gut. One of the roles of vri in the embryo appears to 
involve the DPP signal transduction pathway during dorsoventral patterning. In 
addition, vri also enhances DPP wing phenotypes and the phenotype of vri 
alleles on wing veins is similar to the dpp shortvein phenotype. During 
patterning and differentiation events of the eye disc in L3, expression of vri 
has been described and mis-regulation indicates that the function of vri 
affects eye development; however, the function is currently unknown 
(Szuplewski et al., 2003). The majority of data on the control of vri 
expression and function comes from studies in the adult where it has been 
shown to be part of the core molecular oscillator mechanism, described 
further in section 1.2 (Blau and Young, 1999; Glossop et al., 2003; Cyran et 
al., 2003). 
 
1.2 The circadian oscillator 
 
The circadian (circa – about : diem – a day) oscillator is a timing mechanism 
that provides organisms with the ability to anticipate daily changes in the 
environment and thus co-ordinate physiological and behavioural events to the 
right time of day, or night. Plants, fungi, animals and prokaryotes show an 
anticipatory circadian rhythmicity in physiology, metabolism and behaviour 
(Vallone et al., 2007; Hardin, 2005). The oscillator is adjusted by 
environmental cues, such as light or temperature (known as zeitgebers – time 
givers), to ensure that the internal clock is synchronised to the time of day 
(Devlin, 2002). This also ensures that the oscillator does not begin to ‘free-
run’, a phenomenon observed when organisms are deprived of environmental 
cues that entrain the oscillator – as the period of the oscillator is not exactly 
24 hours and can drift out of phase when deprived of synchronising cues. So, 
three features describe an oscillator: an environmental input pathway that is 
a zeitgeber; a pacemaker that uses the zeitgeber to synchronise circadian 
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rhythms; and an output pathway mediated by the pacemaker that modulates 
physiology, metabolism and behaviour accordingly. The behavioural 
rhythmicity of an animal is generally measured by examining periods of rest 
and activity, which are controlled by circadian pacemaker neurones in the 
brain. In addition to the central pacemaker neurones, many other peripheral 
tissues contain autonomous circadian oscillators (Plautz et al., 1997). 
Outlined below are some of the molecular features of the oscillator and the 
organisation of the circadian system. 
 
1.2.1 The molecular pacemaker of flies 
 
An oscillator manifests as cycling of transcript and protein levels of circadian 
genes that interact in feedback loops and result in rhythmic output of the 
pacemaker (see Figure 1.2; Hardin, 2005; Glossop et al., 1999; Glossop and 
Hardin, 2002; Cyran et al., 2003). The interlocked-feedback loop model, 
originally shown by Glossop et al. (1999), was formed to illustrate the 
activation and repression of genes that drive rhythmicity. It consists of a 
negative loop (the per/tim/cwo loop) and a stabilising loop (the vri/Pdp1! 
loop; Lee et al., 1999; Blau and Young, 1999; Glossop et al., 2003; Cyran et 
al., 2003; Lim et al., 2007; Matsumoto et al., 2007; Richier et al., 2008). 
Post-transcriptional and post-translational mechanisms operate on these loops 
to ensure that protein activity is tempero-spatially regulated. The core of the 
oscillator consists of seven proteins: three that act as transcriptional 
activators; three that act as repressors of transcription or protein function; 
and, one that has a context-dependent role. The transcriptional activators are 
CLOCK (CLK) and CYCLE (CYC) of the basic helix-loop-helix/ Per-Arnt-Sim 
(bHLH/PAS) domain transcription factor family, and PAR Domain Protein 1# 
(PDP1#), a PAR bZip transcription factor (Cyran et al., 2003; Bae et al., 1998; 
Benito et al., 2007). The inhibitors are VRILLE (VRI), a bZip factor, TIMELESS 
(TIM) and the PAS domain protein PERIOD (PER) Glossop et al., 2003; Cyran et 
al., 2003; Lee et al., 1999). CLOCKWORK ORANGE (CWO), a bHLH-Orange 
transcriptional repressor, has context-dependent roles (Lim et al., 2007; 
Matsumoto et al., 2007; Richier et al., 2008). CWO appears to be a modulator 
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of the oscillator having a complex role that appears to have repression and 
activation elements that are also mediated via E-boxes. CYC is constitutively 
expressed (Bae et al., 2000; Kilman and Allada, 2009), while Clk gene 
expression is rhythmic and CLK protein undergoes rhythmic phosphorylation/ 
de-phosphorylation (Kim et al., 2002; Houl et al., 2006; Houl et al., 2008). 
The other five all show rhythmic mRNA and protein levels. 
 
 
Figure 1.2 The core oscillator mechanism. The interlocked feedback loop model that 
generates rhythmic mRNA and protein levels, which in turn regulate rhythmic activity. CLK, 
CLOCK; CYC, CYCLE; VRI, VRILLE; PDP1#, Par Domain Protein 1#; TIM, TIMELESS; PER, PERIOD. 
Lines with a bar indicate inhibition/ repression; solid line arrows indicate activation; dashed 
line arrow indicates omitted process (of Clk mRNA export from nucleus, translation of CLK 
protein, dimerisation with CYC and re-entry into the nucleus to activate transcription); E-box, 
DNA sequence bound by CLK-CYC heterodimer; V/P-box, DNA sequence bound by VRI and 
PDP1#; double line circle, nuclear envelope (Hardin, 2005). 
 
CLK and CYC form heterodimers that bind to E-box regulatory elements to 
initiate transcription of per, tim, cwo, Pdp1! and vri (and other clock-
controlled genes) from the middle of the day into early night (see Figure 1.3; 
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reviewed in Hardin, 2005; Lim et al., 2007; Richier et al., 2008). Transcripts 
of per, tim and cwo accumulate to peak levels in the early night but post-
translational mechanisms (kinase-driven phosphorylation and protein 
instability) delay accumulation of the proteins reaching peak levels late in the 
night. Following stabilisation of PER and TIM proteins, they feedback to 
regulate their own transcription by inhibiting the activity of CLK-CYC. This 
inhibition has not been fully resolved as yet but involves multiple components 
including inhibition by the binding of PER:PER and PER:TIM dimers directly to 
CLK-CYC and phosphorylation of CLK (Landskron et al., 2009). The actions of 
CWO are also likely to contribute to the inhibition of CLK-CYC function. In 
vitro data suggest strong repression of E-box genes by CWO, an observation 
that is consistent in vivo with respect to auto-regulation – null mutants have 
elevated levels of cwo transcripts (Lim et al., 2007; Matsumoto et al., 2007; 
Richier et al., 2008). Post-translational differences in CLK and PER 
phosphorylation are also seen in cwo null mutants. In addition, the transcript 
levels of other E-box genes, per, tim, vri and pdp1# are reduced in the null 
mutant suggesting activation of these genes. It is possible, however, that 
some observations are the result of indirect effects. 
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Figure 1.3 Protein and mRNA cycling over a 24 hour period. The relative levels of mRNA or 
protein at a given point over one light-dark cycle. Diagram is illustrative not quantitative. 
Purple dashed line, Clk mRNA; green solid line, PDP1# protein; orange solid line, PER and TIM 
protein; orange dashed line, per, tim and vri mRNA levels; red solid line, VRI protein. Vertical 
lines on graph related to timeline shown below graph, time is in hours and black box indicates 
dark phase. 
 
Translation of VRI protein is in phase with the accumulation of vri mRNA; the 
protein homodimerises, binds to VRI/PDP1# box (V/P box) regulatory elements 
on the Clk gene and inhibits transcription of Clk (Glossop et al., 2003; Hardin, 
2005; Cyran et al., 2003). Clk mRNA thus cycles in antiphase to CLK-CYC-
driven, E-box regulated transcripts. PDP1# accumulates with the same phase 
as PER and TIM though reasons for the lag between transcription and 
translation are not clear. PDP1# recognises the same sites as VRI and is able to 
activate Clk transcription from the V/P box (Cyran et al., 2003). Although 
PDP1# can activate Clk expression, it is not required for rhythmic Clk 
expression, rather, it mediates rhythmic output locomotor activity (Benito et 
al., 2007; Zheng et al., 2009). PDP1# is a conditional activator of Clk and is 
dependent on CLK-CYC itself for initial activation as observed by the lack of 
PDP1# in the Clk and cyc mutants, ClkJrk and cyc01. In addition, an isoform 
specific mutant of Pdp1! exhibits arrhythmic behaviour and CLK protein levels 
are reduced but, crucially, present at low levels. Moreover, the mutant 
alleles ClkJrk and cyc01 produce non-functional proteins that are unable to 
mediate oscillator functions. Both mutants show constitutively high levels of 
Clk mRNA but low levels of the genes they activate (including Pdp1!), which 
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indicates that Clk must also be activated by other factor/s (Cyran et al., 
2003). An analysis of Clk promoter and enhancer regions reveals 
heterogeneity in the regulation of Clk expression within subsets of oscillator 
neurones (Gummadova et al., 2009). Gummadova et al., (2009) examined 
various enhancer and promoter regions of Clk and identified subsets of the 
central brain oscillator neurones that are differentially controlled by these 
enhancers. These were designated as type-A and type-B. Type-A expression is 
mediated by a construct of the Clk promoter that lacks V/P boxes (see section 
1.2.2 for information about neuronal subsets). Two interesting features to 
note about type-A expression are, (1) it is not mediated by PDP1# and, (2) the 
neurones represented more closely resemble a subset that is expressed earlier 
in development. This suggests a subset of neurones in which Clk is activated 
by a different regulator or by PDP1# either, indirectly or, via non-canonical 
binding sites. Type-B expression is observed in the remaining subsets of 
oscillator neurones, in addition to expression within the type-A subsets. The 
type-B enhancer is an extension of the type-A enhancer and contains one V/P 
box. 
 
Recent data from Glossop et al. (unpublished results) indicate that TOY may 
regulate Clk expression. Several TOY/ EY binding sites were found in the Clk 
locus and over-expression of these proteins in a subset of the neurones 
(ventral lateral neurones, below) that drive locomotor behavioural rhythms 
shortens the period of behaviour – indicating an interaction with the 
oscillator. Furthermore, PRs and the central oscillator neurones also show 
endogenous toy/ TOY expression in wild-type adult brains (Glossop et al., 
unpublished results), recently confirmed by Nagoshi et al. (2010). A 
preliminary study of whole head protein extracts show that TOY protein is 
modified over the 24hr period. In wild-type animals, however, this 
modification is dampened by a functioning oscillator mechanism. In the 
absence of the oscillator, it is hypothesised that feedback regulation to 
reduce the amount of modified TOY is removed (see Figure 1.4). 
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Figure 1.4 Western blot of TOY protein from wild-type and oscillator-deficient heads over 
a 24hr LD cycle, provided by Glossop (unpublished data). Heads from wild-type or cyc01 
mutants were collected at ZT4, 10, 16 22 the proteins extracted and compared for TOY-
immunoreactivity in a Western blot. In vitro synthesised TOY protein (TnT-TOY) and an 
unprimed negative control (TnT-empty) were used as a control for the TOY antiserum. In 
wild-type flies the modified TOY protein isoform is dampened whereas oscillator-deficient 
cyc01 mutants have elevated levels during the light phase. This suggests that in the presence 
of an intact oscillator mechanism, TOY protein levels are reduced during the light phase. 
 
1.2.2 Organisation of the central brain circadian neurone 
network 
 
The spatial distribution of oscillator cells in Drosophila is generally described 
as central and peripheral. The central components of the circadian system 
comprise seven neuronal clusters and glia in the central brain and optic lobes 
(Figure 1.5; Helfrich-Förster et al., 2007; Hardin, 2005). The neuronal clusters 
may be placed in one of three categories, the lateral neurones – consisting of 
the dorsal lateral neurones (LNds), small ventral lateral neurones (s-LNvs) and 
large ventral lateral neurones (l-LNvs); the dorsal neurones – consisting of the 
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dorsal neurones (DN) 1s (DN1s), DN2s and DN3s; and the lateral posterior 
neurones (LPNs; Shafer et al., 2006). Of these, the LNvs (and in particular the 
s-LNvs) regulate rhythmic locomotor output, as shown by arrhythmic 
locomotor behaviour when these neurones are electrically silenced or, 
ablated by pro-apoptotic gene expression (Nitabach et al., 2002; Renn et al., 
1999; Stoleru et al., 2004). The s-LNvs project to the ipsilateral accessory 
medulla area (aMe) and the dorsal protocerebrum in the vicinity of the DN2 
and DN3 neurones and the Kenyon cells of the mushroom bodies, centres of 
olfactory learning (de Belle and Heisenberg, 1994; Helfrich-Förster et al., 
2007). The l-LNvs have been found to project mainly to the aMe and the 
medulla of the optic lobe ipsilaterally and contralaterally (via a ventral 
commisure). Helfrich-Förster et al. (2007) suggest that they mediate rhythmic 
signalling to the optic lobe, possibly to action cyclical sensitivity to visual 
perception and connect the aMe regions of the two hemispheres. The LNds 
project to the aMe and the dorsal protocerebrum, both ipsi- and contra-
laterally (via a dorsal commisure) but input to their somata has not been 
deciphered. The DNs input to locomotor rhythm maintenance for crepuscular 
activity under light-dark conditions but not constant environmental 
conditions. Subsets of the DN1 and DN3 neurones project to the ipsilateral 
aMe, whereas DN2s do not. The remaining projections of the DN1-3 groups 
remain within the dorsal protocerebrum, of these DN1 and DN2 neurones cross 
to contralateral hemispheres via the dorsal commisure whereas the DN3 
arborisations remain ipsilateral only. The LPN neurones express oscillator 
factors though their projection patterns remain elusive. It appears then that 
the aMe region is an organising centre receiving the input from several 
oscillator neurone classes and may be involved in the coordination of signals 
between these groups. 
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Figure 1.5 Central oscillator neurones. Figure from Helfrich-Förster et al. (2007), oscillator 
neurone groups of the central brain and their projections: aMe, accessory medulla; lateral 
neurons (LNd, l-LNv, s-LNvs and 5th s-LNv); dorsal neurons (DN1, DN2, DN3); lateral posterior 
neurones (LPN) R1-6, nuclei from photoreceptor cells 1 to 6; R7/8, nuclei from photoreceptor 
cells 7 and 8; H-B, Hofbauer-Buchner; H-B eyelet, extraretinal photoreceptor cluster; H-B 
tract, projection of H-B eyelet to the aMe. 
 
The full context of projections is not, as yet, entirely clear due to resolution 
constraints, especially within the heavily innervated aMe and dorsal 
protocerebrum. What is apparent is that there appears to be cross-talk 
between the different clusters of oscillator neurones, this is postulated to be 
mediated largely by the neuropeptide pigment dispersing factor (PDF) 
secreted by the small and large LNvs (Peng et al., 2003; Stoleru et al., 2004; 
Im and Taghert, 2010). The PDF receptor, PDFR, a G-protein coupled 
receptor, is expressed in a large subset of the oscillator neurones, in the 
visual system and non-oscillator cells of the brain (Im and Taghert, 2010). 
Synchronicity between the oscillator neurones and the behavioural output rely 
heavily on this PDF signalling (Peng et al., 2003; Stoleru et al., 2004; Im and 
Taghert, 2010). 
 
In the context of the Clk promoter analysis carried out by Gummadova et al., 
(2009), the s- and l- LNvs, LNds, two DN1 neurones located anteriorly (DN1a) 
day/night changes that have a ci rcadian basis, e.g., fluc-
tu t ions in axon diameter of lamina monopolar ce l ls, fluc-
tuat ions in the number of synapses in photoreceptor ter-
minals, and fluctuat ions in screening pigments (Pyza and
Me iner tzhagen , 1993, Pyza and Me iner tzhagen , 1995,
Pyza and Me iner tzhagen , 1997a , Pyza and Me iner tzha-
gen , 1999; Me iner tzhagen and Pyza , 1996; Pyza , 2002).
These changes seem to be mediated by PD F and serotonin
that appear both to be re leased cycl ical ly from the i r var-
icose neuri tes in the optic lobe (Pyza and Me iner tzhagen ,
1998; Me iner tzhagen and Pyza , 1999). Rhythmic size
changes of the PD F-immunoreact ive var icosit ies are con-
sistent with this interpretat ion (Pyza and Me iner tzhagen ,
1997b). The findings of H amasaka and N a¨sse l (2006) and
ours with n-syb-G FP are again in l ine with a re lease of
PD F from the l-L Nv var icosit ies.
Synaptobrevin is an integral synapt ic vesicle prote in
that forms a complex with the plasma membrane prote ins
SN AP-25 and syntaxin (Richmond and Broadie, 2002).
This so-cal led SNARE complex is a prerequisi te for exo-
cytot ic membrane fusion , whereby the fusion prote in
n-syb-G FP was found to be a re l iable marker for synapt ic
re lease sites (I to et a l., 1998; Estes et a l., 2000; Morales et
a l., 2002). Synaptobrevin is also involved in the paracr ine
re lease of neuropeptides (L inial, 1997; Renden et a l., 2001;
Voets et a l., 2001), so n-syb-G FP is expected similar ly to
labe l such sites. We found n-syb-G FP specifical ly in the
PD F-immunoreact ive var icosit ies on the medulla surface,
although previous studies have shown that these var icos-
i t ies are vir tual ly devoid of presynaptic specia l izat ions
(Misk iewicz et a l., 2004). We conclude that PD F is re-
leased in a paracr ine manner from the var icosit ies. A
similar re lease mechanism was repor ted for PD F in the
crab Carc i nus maenas (D ircksen , 1992) and the cockroach
Leucophaea mader ae (Re ischig and Stengl, 2003) as we l l
for other neuropeptides that are packed in dense-core
vesicles (Thureson-K le in and K le in , 1990; Schu¨rman et
a l., 1991).
We found the number of var icosit ies formed by one
l-L Nv ce l l to remain rather constant in different individ-
uals but the arbor izat ion pattern of the n urons to be
quite flexible. When one optic lobe was significant ly re-
duced in size, addit ional var icosit ies appeared in the nor-
mal optic lobe. F urthermore, in these cases, the neurons
showed a tendency to project to other brain areas,
whereby these alternat ive target areas were not inciden-
tal ly distr ibuted in the brain . Preferential ly, the l-L Nvs
projected into the oce l lar t ract and thus remained linked
to the visual system . In other cases, they fol lowed the path
of s-L Nv into the dorsal brain .
Thus, the l-L Nv ce l ls appear clear ly associa ted with the
visual system , making a significant contr ibut ion to the
control of behavioral rhythmici ty quest ionable. Consis-
tently with this assumption , several researchers found
F ig. 11. Putat ive arbor izat ion patterns of a l l clock-gene-
expressing neurons (with the exception of the LPN). The central
region of accessory medulla (aMe) is invaded ipsi lateral ly by the
PD F-posit ive s-L Nv, the fifth s-L Nv (dark violet arrowhead in the
r ight hemisphere), the l-L Nv, a few LNds (orange arrowhead), the
DN1a ,p (l i lac arrowhead), and a few DN3 (blue arrowhead), whereas
the ventral e longat ion of the aMe exclusive ly rece ives fibers from the
ipsi lateral l-L Nv (brown arrowhead). Contralateral ly, only the L Nd
(small orange arrow , compare F ig. 10) and the l-L Nv (small brown
arrow , compare F ig. 4) invade the aMe; in both cases, fibers seem
restr icted to i ts central region . Putat ive outputs (presynaptic areas) in
the dorsal protocerebrum were revealed for the PD F-posit ive s-L Nv
nd the L Nd (black arrows).
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and DN2 neurones exhibit type-A expression. Type-A expression is mediated 
by a promoter that lacks V/P boxes and, therefore, lacks binding sites for the 
only currently known activator of Clk – PDP1#. A 122-base pair region is 
implicated primarily for the observed expression. The remaining oscillator 
neurones, posteriorly located DN1s (DN1p), DN3s and LPNs show type-B 
expression. The type-B promoter is an extension of the type-A region and all 
the oscillator neurones of type-A are also revealed by the type-B mediating 
promoter. The majority of cells of type-A expression develop during larval 
stages, namely the s-LNvs, DN1a and DN2 neurones; the remaining oscillator 
neurone subsets developing at later stages. 
 
The locomotor activity patterns of Drosophila in a light-dark cycle show two 
peaks of activity, a morning and an evening peak that are controlled by 
subsets of the pacemaker neurones (Hardin, 2005). The LNvs and LNds are the 
controllers of locomotor activity with the LNvs mediating the morning activity 
peak and the LNds in control of the evening peak of activity (Stoleru et al., 
2004). The LNs have also been found to signal to the prothoracic gland to 
ensure that eclosion of adults from pupae occurs at dawn (Myers et al., 2003). 
 
The peripheral oscillators of Drosophila are found in several tissues, all are 
photoreceptive and are able to function autonomously (Plautz, 1997; 
Ivanchenko et al., 2001; Tanoue et al., 2004). Several sensory tissues have 
been shown to be oscillators, that is the photosensory compound eyes and 
ocelli; mechanosensors of the second antennal segment; and chemosensors of 
the third antennal segment, proboscis, maxillary palps, legs and wings. 
Rhythmic changes in membrane potential gate the responsiveness of the 
neurones and it has been suggested that such changes enable sensory 
neurones to have a dynamic range across which they can sample the 
environment, being most sensitive during periods when the stimulus is 
weakest (Mazzoni et al., 2005; Nitabach et al., 2005). Specific examples of 
circadian changes in peripheral organ function in Drosophila include: the 
observations by Tanoue et al. (2004) that the antennal neurones are both 
necessary and sufficient for maintaining olfactory response rhythms and are 
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truly autonomous as the rhythms persist despite ablation of LNvs. A circadian 
rhythm in visual sensitivity of larvae to maintain the photophobic response 
has also been documented (Mazzoni et al., 2005). The larval photoreceptive 
organ, BO, connects directly to the LNs and together they form a circuit for 
light avoidance behaviour: BO transmits photic signals to the LNs and the LNs 
gate their sensitivity to this information to modulate the behavioural response 
over the course of the day. In addition, compound eye PR neurones show a 
24hr rhythm in plasticity that is cell autonomous in order to maintain optimal 
perception and coding over the high amplitude changes in photic input over a 
24hr period (Barth et al., 2010). 
 
1.3 Aims and outline 
 
In the current study, I aim to investigate links between eye development and 
circadian oscillators. The molecular interactions are examined in order to 
learn more about the intricacies of both systems. I aim to reveal whether eya 
and so are primary targets of VRI during eye development. 
Immunohistochemistry, mis-expression of VRI and enhancer analysis in the 
developing eye disc, and in vitro techniques, are utilised to examine the 
influence of VRI on eya and so regulation in the eye disc. In addition, together 
with data from Glossop et al. (unpublished results), I hypothesise that 
molecular links between circadian and eye development factors enable tissue-
specific circadian physiology in mature PRs. Furthermore, similar interactions 
may take place in the central oscillator neurones. Enhancer analysis, 
immunohistochemistry and in situ hybridisation are used to study expression 
in central brain and mature PRs. 
 
Chapter 2 describes the protocols used in this study and results are shown in 
Chapters 3-5. 
 
In Chapter 3, I examine the expression of VRI in developing eye discs in 
relation to developing PRs and EYA protein. VRI is highly expressed within 
zones I, II and PPN but down-regulated in the zones MF and IV, that is within 
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the PRs as they develop. Over-expression of VRI within the PRs results in cell-
dependent phenotypes. These results suggest a role of attenuation rather 
than absolute regulation by VRI. 
 
In vitro and in vivo studies of VRI binding sites within the eya and so genomic 
loci are described in Chapter 4. An in vitro binding assay shows that VRI binds 
potential regulatory sites within the eya and so loci at varying efficiencies. 
Crucially, two of the identified sites are located adjacent to a well-described 
so enhancer region. The most interesting finding here is that extension of the 
previously described enhancer of so appears to have epistatic effects on EYA 
expression, further reinforcing the close relationship of these two factors. 
 
Chapter 5 shows preliminary data on the photo-dependent circadian 
regulation of eya and so transcripts within wild-type and oscillator-deficient 
adult brains and PRs. Circadian changes were observed in gene expression of 
the wild-type and oscillator-deficient genotypes, this may be a photo-
response and, if so, suggest photoperiodic tracking as observed with 
vertebrate homologues of eya and so. 
 
I conclude in Chapter 6 with a summary of all the results and discussion on the 
outlook and perspectives of this data on forging links between oscillator 
factors and tissue output. 
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Chapter 2 Materials and methods 
 
2.1 Fly strains 
 
Table 2.1 Fly strains. Genotypes of all fly strains used in the current study. 
Type Genotype Other information 
Wild type +; +; + Canton S strain 
Wild type w; +; + standard reference wild type 
Mutant w; +; ClkJrk non-functioning oscillator 
Mutant w; +; cyc01 non-functioning oscillator 
Transgenic w; GMR-Gal4/+; + GMR-Gal4 driver 
Transgenic w; +; UAS-vri-2b VRI responder 
Transgenic w; +; UAS-vri-3 VRI responder 
Transgenic w; +; UAS-n-GFP GFP with nuclear localisation signal 
responder 
Transgenic w; GMR-Gal4/+; UAS-
n-GFP/+ 
GMR-Gal4 mediated nuclear GFP 
expression 
Transgenic w; GMR-Gal4/+; UAS-
vri-2b/+ 
GMR-Gal4 mediated VRI expression 
Transgenic w; GMR-Gal4/+; UAS-
vri-3/+ 
GMR-Gal4 mediated VRI expression 
Transgenic w; GMR-Gal4/+; UAS-
n-GFP/UAS-vri-2b 
GMR-Gal4 mediated VRI and GFP 
expression 
Transgenic w; GMR-Gal4/+; UAS-
n-GFP/UAS-vri-3 
GMR-Gal4 mediated VRI and GFP 
expression 
Transgenic yw; +; so10-Gal4/+ so10 driver, courtesy of W. Gehring 
Transgenic yw; +; so7-Gal4/+ so7 driver, courtesy of W. Gehring 
Transgenic yw; so7+VP-
Gal4[51C]/+; + 
so7+VP driver, produced for this study 
Transgenic yw; so7+VP[VP-mut]-
Gal4[51C]/+; + 
so7+VP[VP-mut] driver, produced for this 
study 
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2.2 In vitro protein synthesis 
VRI protein was synthesised in vitro from pBSIIKS-vri (Glossop et al., 2003) 
using a TnT T3 coupled rabbit reticulocyte lysate kit (Promega) that couples 
transcription and translation of a protein from a DNA template. Reactions 
were carried out according to kit guidelines as follows: 25µl lysate, 2µl TnT 
buffer, 1µl complete amino acid mix, 2µl RNasin (40 U/µl, Promega), 1µg 
cDNA plasmid, 1µl T3 RNA polymerase and made up to 50µl total reaction 
volume with ddH2O; plasmid DNA was omitted for the un-primed negative 
control. Reactions were incubated at 30ºC for 90min. 
 
2.3 Western blotting 
 
Lysates were analysed on a western blot. 5µl of VRI or un-primed lysate (10%) 
samples or protein standards ladder (Bio-Rad) was mixed with 5µl ddH2O and 
diluted 1:1 with 2x loading buffer (100mM Tris-Cl [pH 6.8], 4% SDS [v/v], 0.2% 
Bromophenol Blue [w/v], 20% glycerol [v/v], 200mM "-mercaptoethanol); 
incubated at 100ºC for 3min; centrifuged at 14000xg for 1min and placed on 
ice. 5% stacking gel (100mM Tris-Cl [pH 6.8] 0.1% SDS [v/v], 5% 29:1 
acrylamide: bis-acrylamide [v/v] set with APS and TEMED) and 7.5% resolving 
gel (400mM Tris-Cl [pH 8.8], 0.1% SDS [v/v], 7.5% 29:1 acrylamide: bis-
acrylamide [v/v] set with APS and TEMED) were used. Proteins were run in 
running buffer (25mM Tris, 190mM glycine) at 100V. Trans-Blot SD Semi-Dry 
Electrophoretic Transfer Cell (Bio-Rad) was used to transfer the proteins to 
Hybond-ECL nitrocellulose membrane (Amersham) in blot buffer (48mM Tris, 
39mM glycine, 20% methanol [v/v], 0.0375% SDS [v/v]) at 20V for 1hr. For 
protein detection, the membrane was washed in TST buffer (140mM NaCl, 
10mM Tris, 0.05% Tween 20 [v/v]); then, blocked in TBST buffer (5% skimmed 
milk powder [w/v], 5% thimerosol [v/v] in TST) for 1hr with agitation. 
Membrane was incubated overnight with agitation at 4ºC in guinea pig anti-VRI 
(GP-!-VRI), 1:2000 in TBST followed by several washes in TST. Membrane was 
then incubated with horseradish-peroxidase-conjugated goat anti-guinea pig 
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secondary antibody (Sigma-Aldrich), 1:1000 in TBST followed by several 
washes in TST. 1ml of ECL detection reagents A and B (GE Healthcare) were 
added to the membrane and agitated for 1min and autoradiographed to 
detect protein bands. 
 
2.4 Immunohistochemistry (IHC) procedure 
 
2.4.1 Protocol 
Wandering L3 larvae CNS or 3-5 day old adult brains were dissected in 
phosphate buffered saline (PBS, 137mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 
1.8mM KH2PO4) and transferred to 4% paraformaldehyde (PFA [w/v]) in PBS. In 
the case of larvae, the CNS and attached discs were transferred; 5-6 larvae 
were dissected for so intron six enhancer analysis, in all other instances, 9-13 
larvae were dissected. Males and females, 3-4 of each, were dissected for 
adult brains at each zeitgeber time (ZT), ZT3, 9, 15 and 21. Fixations 
proceeded for 20min followed by several washes with PBX (0.3% Triton X-100 
[v/v] in PBS). Tissue was blocked in PXDN (0.3% sodium deoxycholate [v/v] 
and 5% normal donkey serum [v/v] in PBX) for 1hr, then incubated overnight 
with primary antibodies in PXDN at 4ºC. Samples were washed several times 
with PBX followed by secondary detection with fluorophore-conjugated 
antibodies in PXDN for 1-2hrs at room temperature in the dark. After several 
washes with PBX, samples were mounted in Mowiol 4-88 (Calbiochem) 
containing 2.5% diazabicyclo [2.2.2] octane (DABCO) [w/v] antifade reagent 
and stored at 4ºC in the dark. 
 
2.4.2 Antibodies 
 
Primary antibodies used were: GP-!-VRI (1:500, (Glossop et al., 2003)); rat 
anti-ELAV (1:200); rabbit anti-PDP1 (1: 2500, (Reddy et al., 2000)); mouse 
anti-EYA (1:10, eya10H6 by Benzer and Bonini from the Developmental Studies 
Hybridoma Bank); Guinea Pig 50 anti-CLK (CLK-GP50, 1:3000, (Houl et al., 
2008)). 
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For pre-absorption of antibody, in vitro synthesised VRI protein lysate, or 
unprimed control lysate (-ve) were mixed at 1:10 together with GP-!-VRI and 
incubated on ice for 15min prior to applying to tissue. 
 
Secondary antibodies were all used at 1:200: donkey anti-guinea pig-Cy5; 
donkey anti-rat-FITC; donkey anti-rabbit-FITC; donkey anti-mouse-Cy3 (all 
from Jackson Immunoresearch from Stratech Scientific Limited, UK). 
 
2.4.3 Confocal microscopy and image preparation 
 
Images were collected on a Leica TCS SP5 AOBS upright confocal using a 63x/ 
1.40 Plan Apo objective and confocal zoom was used. The following settings 
were always kept the same: pinhole – 1 airy unit; scan speed – 400Hz 
unidirectional; format 512 x 512. For GFP/ FITC detection, excitation (ex): 
488nm, emission (em): 500-535nm; Cy3 detection, ex: 543nm, em: 556-
610nm; Cy5 detection, ex: 633nm, em: 650-750nm; using the 488nm (20%), 
594nm (100%) and 633nm (100%) laser lines, respectively. Individual channels 
were scanned sequentially and data is presented as single Z-sections or 
maximally projected stacks, refer to figure legend. 
 
Basic functions included in the MBF ImageJ bundle were used for preparation 
and analysis of images. 
 
2.5 Pharate adult preparation 
 
2-4 day old pupae were collected, the pupal case was opened at the anterior 
and fixed in 4% PFA overnight. Fixed pharate adults were removed from the 
pupal case and imaged under PBS with a Leica MZ10 F microscope using a DFC 
420C camera and processed with the Leica Application Suite, version 3.6.0, 
build 488. 
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2.6 Electrophoretic Mobility Shift Assays 
 
2.6.1 Data mining 
 
The consensus binding site for VRI has been previously described (Glossop et 
al., 2003) using the optimal binding site of the bZip protein E4BP4/ NF-IL3A as 
a basis (Cowell et al, 1992): (G/A/T)T(T/G)A(T/C): GTAA(T/C). E4BP4/ 
NF-IL3A is the human homologue of VRI and shares 60% identity in 68 amino 
acids of the bZip domain, which translates to 93% similarity (George and 
Terracol, 1997). This similarity in identity in the bZip domain results in a 
similarity in consensus binding sites. There are some subtleties in binding site 
preference evident by the flanking and internal ‘wobble’ bases. For this 
reason, the core 8 bases of the consensus binding site, excluding bases -5 and 
+5, were used in data mining of genomic regions containing the eya and so 
loci (GenBank accession numbers, eya: AC092230 and AC011249; so: AC009739 
and AC008258). Genomic and transcript sequences, obtained from FlyBase 
(Tweedie et al., 2009), were aligned to demarcate the exon/ intron 
boundaries of genes by carrying out a transcript to genomic DNA alignment 
using the Spidey tool on NCBI. The core of the consensus sites was then 
mapped onto the genomic sequences. 
 
Sites from each gene were selected for electrophoretic mobility shift assays 
(EMSA) to verify the ability of VRI to bind to these sequences. Sites that were 
non-consensus at bases -5 and/or +5 of the search site were included to 
determine whether VRI does recognise the selected sequences. Selected sites 
were also mutated to demonstrate specific sequence-dependent binding. 
 
2.6.2 Probe preparation 
 
The V/P box appearing in the Clk locus at -209 was previously shown to be 
recognised and bound well by VRI (Glossop et al., 2003) and was therefore 
used as a positive control. Commercially synthesised (Sigma Aldrich, UK) sense 
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and corresponding anti-sense strands were used that contain the 10 bases of 
the VRI binding site flanked by 5 nucleotides on both, 5’ and 3’, ends (sense 
strands in Table 2.2 ). 
 
Table 2.2 Oligonucleotides used for EMSA. Only the sense strand sequence is shown and 
given 5’ to 3’. Consensus site is in uppercase, the core 8 bases used for data mining are 
italicised and mutated bases are underlined. 
Name Description Sequence 
C Clk-209 (positive control) attcaATTACATAACctggc 
e1 eya – upstream cactgGTTACATAAAcagca 
e2 eya – upstream tagttATTACATAACctcgc 
e2M mutated e2 tagttAGTACAATTActcgc 
e3 eya – upstream tctgtTTTATGTAAAcatgt 
e4 eya – intronic aaaaaTTGATGTAAAacatt 
e5 eya – intronic tgcgaATTATGTAAAatttg 
e5M mutated e5 tgcgaTAATTGTACAatttg 
e6 eya – downstream aataaTTTACATCAAaaagc 
s1 so – upstream ttaatCTTACATCAAtcact 
s2 so – upstream ctgttATTATGTAAAtttta 
s3 so – intron 6 tttcgGTTACATAAAtatcc 
s3M mutated s3 tttcgGGTACAATTAtatcc 
s4 so – intron 6 tggggATTACATAAAagttg 
s4M mutated s4 tggggAGTACAATTAagttg 
 
Clk-209 was labelled with digoxigenin (DIG) using the DIG Gel Shift Kit, 2nd 
Generation (Roche Applied Science) according to kit guidelines. Briefly, 2µM 
sense and anti-sense oligonucleotide strands were annealed in TEN buffer 
(10mM Tris, 1mM EDTA, 0.1M NaCl, [pH 8.0]) by heating to 95ºC for 10min and 
allowing to cool slowly to room temperature. Double-stranded probes are 3’-
end labelled with DIG by terminal transferase in the presence of 0.05M DIG-
ddUTP, 5mM CoCl2 and labelling buffer (all reagents included in kit) at 37ºC 
for 15min; reaction was terminated by the addition of 2µl of 0.2M EDTA [pH 
8.0] and volume increased to 25µl with ddH2O. 
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Labelling was verified by spotting a dilution series of the reaction, together 
with a pre-labelled control included in the kit, onto positively charged Nylon 
membrane (Roche Applied Science) and UV cross-linked at 2000J. Membranes 
were washed in EMSA washing buffer (EWB, 0.1 M Maleic acid, 0.15 M NaCl, 
0.3% (v/v) Tween 20; [pH 7.5]) and blocked for 30min in EMSA blocking buffer 
(EBB, 1% blocking reagent in EWB). Anti-digoxigenin conjugated with alkaline 
phosphatase (anti-DIG-AP) was added at 1:10000 in blocking buffer and the 
membrane incubated for 30min. The membrane was washed 2 x 15min with 
washing buffer and equilibrated in detection buffer (0.1 M Tris-HCl, 0.1 M 
NaCl; [pH 9.5]) for 5min. Membrane was incubated with chemiluminescent 
detection reagent CSPD at 1:100 in detection buffer in the dark for 5min at 
room temperature followed by 10min at 37ºC. Signal was detected by 
exposing photographic film (Kodak Biomax XR) to the membrane. Labelled 
probes were only used if labelling efficiency was equivalent or better than the 
pre-labelled control included in the kit, determined by qualitative comparison 
of the dilution series. 
 
Labelled probes were used in a competition assay with sites selected from eya 
and so loci and compared to self-competition between labelled and 
unlabelled Clk-209 probes. Individual sense and anti-sense strands of all 
unlabelled probes were used at 10µM, mixed and heated to 95ºC for 10min to 
denature and allowed to reach room temperature naturally to anneal. 
 
2.6.3 Binding reaction 
 
Reactions were carried out according to DIG Gel Shift Kit, 2nd Generation 
(Roche Applied Science) guidelines. 20µl reactions were prepared: 12.5% TnT 
reticulocyte lysate (VRI or control, [v/v]); binding buffer (10mM HEPES, 20mM 
KCl, 0.8mM EDTA, 0.4mM dithiothritiol (DTT), 4% glycerol); 1µg sheared 
salmon sperm DNA (Ambion Inc.); 1µl (0.156pmol) labelled probe and 1µl 
(10pmol) unlabelled competitor probe. Reactions were incubated at 30ºC for 
20min, then run on 7% native polyacrylamide gels (0.5x Tris-borate-EDTA 
buffer [TBE, 1x is 90mM Tris-borate, 2µM EDTA], 7% 29:1 acrylamide: bis-
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acrylamide set with APS and TEMED) in 0.5x TBE buffer at 100V for 1hr. A 
marker lane containing loading dye (0.25% Bromophenol Blue [v/v], 0.25% 
xylene cyanol [v/v], 4% glycerol [v/v]) was run alongside as an approximation 
of the position of the free, unbound probe. Probes were transferred from the 
gel onto positively charged nylon membrane using Trans-Blot SD Semi-Dry 
Electrophoretic Transfer Cell (Bio-Rad) in 0.5x TBE for 1hr at 20V followed by 
cross-linking at 2000J. Membrane was washed with EWB, blocked for 30min in 
EBB and incubated with anti-DIG-AP 1:10000 in EBB for 30min. Following 
washes, membrane was equilibrated in detection buffer for 5min, incubated 
for 5min at room temperature with CSPD 1:100 in detection buffer in the dark 
and further developed for 10min at 37ºC. Signal was detected by exposing the 
membrane to photographic film. 
 
2.7 Production of transgenic animals 
 
2.7.1 General methods for cloning 
 
XL1-Blue (Stratagene) competent cells were used for all cloning steps and 
grown on agar plates or medium based on standard lysogeny broth (LB, 1% 
NaCl [w/v], 1% tryptone [w/v], 0.5% yeast extract [w/v]) with the selective 
antibiotic, 75µg/ml carbenicillin (an ampicillin analogue, Sigma Aldrich), 
when necessary. Heat shock transformation was used as standard and bacteria 
were grown at 37ºC as standard when used for cloning of the heat shock 
promoter or Gal4 in isolation. For all steps involving cloning of the enhancer 
from intron 6 of so, so7+VP, and any modifications or additions to this region, 
bacteria were grown at 30ºC for 20-24hrs. Sequences were examined using 
4peaks (Mekentosj) or FinchTV (Geospiza) abi trace viewers and verified using 
BCM Search Launcher and ClustalW online software tools. Verified sequences 
were stored and processed in Microsoft Word or ApE plasmid software, ApE 
was also used to produce the plasmid map shown in Figure 2.1. 
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Plasmid purification from bacterial colonies was done with standard phenol, 
choloroform, isoamly alcohol, 25:24:1 (P:C:IAA) extraction or using Qiagen 
plasmid purification kits according to kit guidelines. Identity and orientation 
of cloned sequences was initially analysed by multiple restriction digests 
(restriction enzymes from New England Biolabs or Roche Applied Science), 
followed by sequence verification using Big Dye v3.1 Terminator kit (Applied 
Biosystems) and processed by the in-house DNA sequencing facility at the 
Faculty of Life Sciences. so7+VP contained some minor differences to those 
published for the so locus (GenBank accession numbers: AC009739 and 
AC008258), these were considered to be polymorphisms so were not mutated 
to the published sequence. None of the VRI, EY, TOY or SO sites were affected 
by the polymorphisms. No mutations were found in the attB site, hsp70 basal 
promoter or Gal4 coding region. 
 
2.7.2 Amplification of so7+VP 
 
Genomic DNA was extracted from wild type Canton S flies to use as the DNA 
template for amplifying 3947bp of intron 6 of so. 25 flies were homogenized 
on dry ice in solution A (0.1M Tris-HCl, [pH 9.0], 0.1M EDTA, 1% SDS [v/v]) and 
incubated at 70ºC for 30min. 8M KAc was gently mixed into the homogenate, 
incubated on ice for 30min and the homogenate centrifuged for 15min at 
13000xg to remove chitinous solid matter. DNA suspended in the supernatant 
was extracted by 2x phenol: chloroform: isoamyl alcohol (P:C:IAA, 25:24:1, 
Sigma Aldrich) extractions according to standard methods, precipitated with 
isopropanol and resuspended in Tris-HCl EDTA (TE, 10mM Trish-HCl, 1mM 
EDTA, [pH 7.5]) buffer.  
 
This purified genomic DNA was used as the template for amplification of the 
region of interest using PCR with the following primers (5’-3’):  
sense – atataaTCTAGAGCATTCTGGCATTCTGGGACTTTCG; anti-sense – 
aaaaaACCGGTGAATTCCTGATCTTAGTAGCCATTC (lower case are extra bases 
for restriction digestion of the PCR fragment prior to cloning, bold and 
italicised are restriction sites for XbaI and AgeI, respectively). Phusion High-
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Fidelity PCR kit (Finnzymes, distributed by Thermo Fisher Scientific) was used 
for amplification according to guidelines, cycling conditions are given in Table 
2.3 (Eppendorf Thermocycler used for PCRs). 50ng genomic DNA was mixed 
with HF buffer, 200µM each dNTP, 0.5µM forward and reverse primers and 1U 
Phusion DNA polymerase. 
 
Table 2.3 PCR settings for amplification of so7+VP from genomic DNA. 
Step Time (mm:ss) Temp. (°C.) 
1 00:30 98 
2 00:10 98 
3 00:30 65.3 
4 02:00 72 
5 Go to step 2 x5 
   
6 00:10 98 
7 02:30 72 
8 Go to step 6 x30 
9 10:00 72 
10 END  
 
PCR product size and quality was checked on a 1.2% agarose gel in Tris-
acetate-EDTA (TAE, 40mM Tris-acetate, 1mM EDTA, [pH 8.5]) buffer. The 
correct product was excised from the gel and purified using the Qiagen gel 
extraction kit according to kit guidelines. Phusion DNA polymerase produces 
blunt-ended products, A-tails were added to the PCR product by incubation 
with ThermoPol buffer (New England Biolabs), 300µM dATP (Bio-Rad), 2.5U 
Taq DNA polymerase (New England Biolabs) for 10min at 72ºC. The product 
was purified using the Qiagen PCR purification kit according to kit guidelines 
and TA-cloned into pGEM-T Easy (pGEM-TE) plasmid vector (Promega) at a 1:3 
vector:PCR product ratio with T4 DNA ligase (New England Biolabs) at 16ºC 
overnight.  
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2.7.3 Amplification of basal promoter 
 
A basal heat-shock promoter, hsp70, was amplified from pCaSpeR-hs 
(GenBank accession number U59056) using (5’-3’):  
sense – aaaaACCGGTGAGCGCCGGAGTATAAATAG; anti-sense – 
ataaGGATCCTATTCAGAGTTCTCTTCTTGTATTC (lower case are extra bases for 
restriction digestion of the PCR fragment prior to cloning, bold and italicised 
are restriction sites for AgeI and BamHI, respectively) (Pelham and Bienz, 
1982; McGarry and Lindquist, 1985). Similarly to the intron region, Taq DNA 
polymerase (New England Biolabs) was used for amplification followed by 
purification and TA-cloning into pGEM-TE vector (Promega), cycling conditions 
are described in Table 2.4. 
 
Table 2.4 PCR settings for amplification of basal promoter of heat shock promoter hsp70 
from pCaSpeR-hs. 
Step Time (mm:ss) Temp. (°C.) 
1 02:00 94 
2 00:30 94 
3 00:15 51.6 
4 00:45 72 
5 Go to step 2 x5 
  
6 00:30 94 
7 00:15 61.8 
8 00:45 72 
9 Go to step 6 x24 
10 05:00 72 
11 END  
 
2.7.4 Engineering of transgenic construct so7+VP 
 
The multiple cloning site of pBSIIKS (GenBank accession number X52329) was 
modified for sub-cloning of enhancer and transgenes, restriction sites in the 
following order were used: XbaI, AgeI, BamHI and NotI, referred to as pBS-M. 
pBS-M and pGEM-TE-so7+VP were digested with XbaI (Roche Applied Science) 
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and AgeI (New England Biolabs) and ligated with T4 DNA ligase, to generate 
pBS-M-so7+VP. pBS-M-so7+VP and pGEM-TE-hsp70 were both digested with 
AgeI and BamHI (New England Biolabs) and ligated to make pBS-M-
so7+VP+hsp70. pBS-M-so7+VP+hsp70 and pGaTB were digested with BamHI and 
NotI (Roche Applied Science) to excise Gal4 coding region (Brand and 
Perrimon, 1993) and ligated to make pBS-M-so7+VP+hsp70+Gal4. The driver 
transgene so7+VP+hsp70+Gal4 was excised using XbaI and ligated into pattB 
which contains the attB site for $C31 integrase-mediated site-directed 
insertion into genomic attB sites (Bischof et al., 2007). 
 
2.7.5 Engineering of transgenic construct so7+VP[VP-mut] 
 
VRI binding sites in the so7+VP transgenic construct, s3 and s4, were mutated 
to the same sequences that eliminated VRI binding in EMSA to make the 
so7+VP[VP-mut] construct. This was done sequentially using QuikChange 
Lightning Site Directed Mutagenesis kit (Stratagene) according to kit 
guidelines with some minor modifications: 150ng template DNA (plasmid) and 
10µM primers were used. More extensive changes were made than suggested 
within the guidelines as previous reports have suggested the mutagenesis 
protocol can be successful under less stringent conditions than single base 
changes (Geiser et al., 2001). Primers used for mutagenesis were, site s3: 
gcatctagagcattctggcattctgggactttcgGGTACAATTAtatccgattaatgac
ctcaggttgaaagg.        Site s4, 
gtaaacctcaaagtgctgaaaagacttggggAGTACAATTAagttggattgccatcggc
ggggggcctgggg. For both, direction is 5’-3’; only sense sequence is given; 
EMSA oligonucleotide primer is in bold, VRI binding site is uppercase, mutated 
bases are underlined and italicised. Cycling conditions are described in Table 
2.5 and the final construct map shown in Figure 2.1.  
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Table 2.5 PCR settings for mutagenesis of sites s3 and s4 in so7+VP using QuikChange 
Lightning site directed mutagenesis. 
Step Time (mm:ss) Temp. (°C.) 
1 01:00 95 
2 01:00 95 
3 02:00 52 
4 06:00 68 
5 Go to step 2 x5 
  
6 01:00 94 
7 02:00 58 
8 06:00 68 
9 Go to step 6 x13 
10 10:00 68 
11 END  
 
 
Figure 2.1 Map of final construct. Final construct showing the relative position of so7+VP, 
hsp70 basal promoter and Gal4 coding region in relation to transgenic (attB site, mini-white 
gene) and plasmid (ampicillin resistance, F1 and ColE1 origin gene) features. 
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2.7.6 Transgenesis 
 
Site-directed transgenesis (Bischof et al., 2007) at landing site 51C was used 
for production of transgenic animals. Integrase transposase enzyme $C31 is 
transgenically expressed within germline cells and mediates insertion of attB 
sequence (and adjacent DNA) within donor attP sites such that both sites are 
then eliminated. The attP cassette in this case is located within a single 
specific region of the genome (chromosome 2L, 51C) and plasmid pattB 
contains the transgene synthesised here and the mini-white gene for selection 
of successful transgene insertion. Sequence verified pattB plasmids containing 
either, so7+VP or so7+VP[VP-mut], followed by hsp70 basal promoter and Gal4 
coding region, were sent to Best Gene Inc. (Chino Hills, California, U.S.A.) – a 
company dedicated for Drosophila embryo injection for transformation with 
transgenic constructs. Flies with eye colour (mediated by the mini-white gene 
for selection of successful insertions into the genome) were, thus, generated 
externally and the chromosome containing the transgenic integrase 
transposase was negatively selected. 
 
2.8 In situ hybridisation 
 
2.8.1 Probe synthesis 
 
DIG-labelled mRNA probes were prepared for in situ hybridisation according to 
guidelines for the DIG-UTP RNA labelling mix. Briefly, single cutter restriction 
enzymes (New England Biolabs or Roche Applied Science) were used to 
linearise 10µg of plasmid DNA and, after verification of digestion, purified 
according to standard P:C:IAA protocols. DIG-UTP RNA labelling mix (Roche 
Applied Science) containing 10mM ATP, CTP, GTP (each), 6.5mM UTP and 
3.5mM DIG-11-UTP was used for the synthesis of DIG labelled probes by Sp6 
(for anti-sense) or T7 (for sense) RNA polymerase (Promega) to yield full 
length mRNA probes. A 3’ UTR-specific probe for so was also tested but found 
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to be insufficient. BDGP DGC full length cDNA clones were used, eya – 
GH05272 (GenBank Accession number, AY047539); so – GH15741 (GenBank 
Accession number, AY060309). Template DNA was denatured at 55°C for 2min 
and transferred to ice prior to addition of 2µl NTP mix, 4µl 5x transcription 
buffer, 1µl RNasin (40U/µl), 1µl 100mM DTT, ddH2O to 18µl and 2µl RNA 
polymerase. The transcription reaction proceeded for 1hr at 37°C. Following 
transcription, the DNA template was eliminated using 2µl of DNase (RQ1, 
RNase-free; Promega) at 37°C for a further 30min and 2.5µl of 0.5M EDTA was 
added to end the DNase reaction. Probes were precipitated by incubation at  
-20°C overnight with 0.1x volume 4M LiCl and 3x volume 100% ethanol, 
followed by centrifugation at 4°C at 15000xg for 15min; and alcohol 
precipitated as standard. The RNA pellet was re-suspended in 99µl ddH2O and 
1µl RNasin was added before aliquoting and storage at -80°C. Probe 
concentration was determined prior to use for each aliquot (NanoVue, GE 
Lifesciences) 
 
2.8.2 Preparation of tissue sections on slides 
 
Male and female 3-5 day old adults of wild-type (w; +; +) and cyc01 mutants 
raised at 25ºC in a 12:12 L:D cycle were collected at ZT2, 6, 10, 14, 18 and 
22. Light exposure to flies collected during the dark phase was minimised, 
flies were decapitated and immersed in TissueTek O.C.T. (Sakura) 
cryosectioning media prior to being set on dry ice. Heads were sectioned on 
an RNaseZap (Ambion Inc.) treated Leica CM3050S Cryostat, chamber 
temperature -20ºC, object temperature -18ºC and collected on Polysine 
coated slides (VWR International). Sections were 18µm thick and arranged 
such that two ZT collections of each genotype were on the same slide. 
Sections were dried at room temperature overnight. 
 
2.8.3 Hybridisation and detection 
 
Chapter 2 Materials and methods 
57 
Protocol is based on that described by Schaeren-Wiemers and Gerfin-Moser 
(1993) and adapted by Vosshall et al., (1999). Tissue was fixed with 4% PFA 
for 10min, washed with PBS and acetylated for 10min in 1% triethanolamine 
solution containing 1:400 acetic anhydride. Pre-hybridisation was carried out 
at room temperature with hybridisation buffer to cover sections (50% 
formamide, 5x SSC [150mM NaCl, 15mM sodium citrate, pH adjusted to 7.0 
with HCl], 5x Denhardts [Fisher Scientific; 1% Ficoll 400, 1% 
polyvinylpyrrolidone, 1% bovine serum albumin], 500#g/ml salmon sperm DNA 
[Ambion Inc.], 30#g/ml heparin [Sigma], 2.5mM EDTA, 0.1% Tween-20 and 
0.25% CHAPS). Coverslips (Hybrislips, Sigma Aldrich) were gently placed on 
top of the slides to prevent dehydration and the chamber humidified with 5x 
SSC, sealed with parafilm to prevent evaporation, and incubated at 60°C for > 
1hr. Probes, 200ng per ml in hybridisation buffer, were denatured prior to use 
and incubated at 60ºC for 16-24hr in a 5x SSC humidified chamber. Several 
post-hybridisation washes were carried out, firstly at 72ºC with 5x SSC, then 
with 0.2x SSC with a final wash with 0.2x SSC at room temperature. 
 
For detection of probes, slides were washed with maleic acid buffer (0.1M 
maleic acid, 0.15M NaCl, 0.1% Triton X-100 [pH 7.5]) and blocked with maleic 
acid blocking buffer (0.1% blocking reagent [Roche Applied Science] in maleic 
acid buffer) for 1hr at room temperature. Anti-DIG- alkaline phosphatase 
(anti-DIG-AP; Roche Applied Science) was added 1:5000 in maleic acid 
blocking buffer and incubated at room temperature for 1hr. Following maleic 
acid buffer washes, and equilibration in detection buffer (100mM Tris-HCl, 
100mM NaCl, 5mM MgCl2, 0.1% Tween20, [pH 9.5]), NBT/ BCIP (18.75 #g/#l 
NBT, 9.4 #g/#l in 67% DMSO BCIP (v/v); Roche Applied Science) was applied 
and the slides allowed to develop overnight in a humidified chamber at room 
temperature in the dark. Chromogenic detection time was optimised to be 
overnight as 30min and 2hr colour development was insufficient. The reaction 
was stopped by immersion in ddH2O and slides mounted in Mowiol 4-88 
(Calbiochem) containing 2.5% DABCO [w/v] antifade reagent and stored at 4ºC 
in the dark. 3DHistech Panoramic Slide Scanner was used to collect images. 
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Chapter 3 Eye disc analysis 
 
3.1 Introduction 
 
3.1.1 Development and differentiation of photoreceptors 
 
Differentiation of PRs commences during the third and final instar of larval 
development (L3). The eye disc is a valuable and extensively employed model 
system for the study of many processes that are reiterated throughout 
development – determination of tissue identity, patterning, axis and 
compartment specification, cell proliferation and apoptosis as well as fate 
specification and polarity. Retinal determination is dependent on highly co-
ordinated convergence of several transcription factors and signal transduction 
pathways. The overall functional output of this convergence is seen as 
sequential development of ordered arrays of cells that form the adult eye 
units, the ommatidia. Cell fate is serially refined and this is observed as 
changes in the complement of transcription factors and signalling pathways 
operating within the cells. According to the progression of cells towards their 
final fate, they are categorised as a part of developmental stage zones within 
the eye disc (see Figure 1.1). Each zone has a different total complement of 
factors that pattern development and the relationships between them are 
dynamic within and between zones according to the entire profile of factors 
present. Thus, it is possible to observe a variety of different functions of 
retinal patterning factors at different positions within the developing eye 
disc. These dynamic functions are determined by the presence or absence of 
whole host of other patterning factors. 
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3.1.2 EYA and SO expression within the eye disc 
 
Two factors, EYA and SO, that pattern the retina show position-dependent 
changes in function and are frequently mentioned with reference to one 
another as they form a heterodimeric transcriptional complex and their 
expression completely overlaps one another. Within the complex, SO has the 
DNA binding domain and EYA has a nuclear translocation signal and 
transactivation potential for gene regulation. Expression of eya and so genes 
is positively regulated by upstream factors EY and TOY just ahead of the MF, 
in the PPN zone, but negatively regulated in zone II cells ahead of the PPN 
zone despite the presence of the positive regulators (see Figure 1.1). 
Therefore, additional factors, or additional roles of currently known factors, 
must be contributing to the observed expression pattern. The transcription 
factor TSH is suggested to repress eya expression within zone II but promote 
expression within the PPN through its interactions with either HTH and EY 
(zone II) or EY alone (PPN). 
 
3.1.3 VRI is proposed as a candidate eye development factor 
 
VRI is a core factor of the molecular circadian oscillator mechanism in which 
it represses expression of the gene Clk. It is also an essential factor during 
several stages of development, though the precise role of VRI during 
development is yet to be determined. Expression of VRI in the developing eye 
disc was first documented by George and Terracol (1997). Szuplewski et al. 
(2003) further explored the eye disc function by disrupting the normal pattern 
of VRI expression in the eye disc and observed developmental phenotypes. 
These consisted of reduction of cell and eye size by creation of mosaic mutant 
cells or disruptions to pattern formation of the eye when VRI was over-
expressed in the eye disc from embryonic stages. However, direct targets for 
VRI regulation during eye development were not determined. Some of the 
observed phenotypes are similar to those observed for established RDGN 
factors (Szuplewski et al., 2003; Cheyette et al., 1994; Bonini et al., 1993) 
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and initial indications from oscillator cells are that that RDGN and oscillator 
factors may interact (Gummadova et al., 2009 and Glossop et al., unpublished 
results). I investigate here the spatio-temporal relationship between VRI and 
that of eya and so in the L3 eye disc. 
 
It is important to note that in parallel to the results described here, eya and 
so genomic loci were examined for VRI binding sites. The preliminary analysis 
revealed several potential V/P boxes and advised the pursuit of determining 
the relationship between VRI/PDP1 and eya/so and are described within this 
chapter. The binding site analyses are elaborated in Chapter 4. 
 
By co-labelling discs, I describe here that VRI is expressed in zones I, II and 
PPN and down-regulated within the MF. In addition, I have determined that 
VRI expression at this time is not dependent on Clk or cyc and that no PDP1 
isoform is present in the L3 eye disc indicating VRI interactions within the eye 
disc are different to those described within the oscillator mechanism. By mis-
expression of VRI in developed PRs, I have tried to determine whether VRI is a 
direct regulator of eya. It appears that a relationship between VRI and EYA is 
not binary but, rather, the data suggest that VRI may attenuate eya 
expression. It is unfortunate that SO antibody was not available to describe 
the relationship between VRI and so expression here. I also show here that 
mis-expression of VRI in the MF and zone IV leads to pupal lethality. 
 
3.2 Results 
 
3.2.1 VRI is down-regulated within the MF 
 
I wanted to firstly to describe the region of VRI expression in the wild type 
eye disc in relation to the developing PRs. It was also of interest to determine 
whether CLK-CYC, the circadian oscillator activators of VRI (Blau and Young, 
1999), also regulate vri expression during eye development by investigating L3 
eye discs of ClkJrk and cyc01 mutants. Two groups of samples were prepared 
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and immuno-stained with GP-!-VRI. For the experiment, GP-!-VRI was pre-
absorbed with unprimed TnT rabbit reticulocyte lysate while the negative 
control was pre-absorbed with TnT lysate primed to make VRI protein. Loss of 
immunoreactivity (IR) in the control would confirm VRI-positive signal 
observed in the experimental. Both lysates were first probed with GP-!-VRI 
on a western blot, two bands were revealed only in the vri-primed lysate as 
described previously (Figure 3.1; Glossop et al., 2003).  
 
 
Figure 3.1 Western blot to show reactivity of unprimed and vri-primed lysate with GP-!-
VRI. Rabbit reticulocyte lysate in vitro transcription/ translation system either, primed with a 
plasmid containing the vri coding region (TnT+), or, unprimed negative control (TnT-). 
Migration of protein standards is shown on the left of the image. 
 
All eye disc images are oriented as shown in the schematic in Figure 1.1A. 
Figure 3.2 shows VRI immuno-labelling in an eye disc co-labelled for the pan-
neuronal marker ELAV. The primary antibody mix was pre-absorbed with 
unprimed TnT lysate. VRI-IR is present in the anterior eye disc up to the MF in 
the PR epithelium (Figure 3.2A) and, at a reduced level, in a few rows of cells 
just posterior to the MF (close-up image shown in Figure 3.2B). 
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Figure 3.2 VRI is expressed in the anterior eye disc and the PE. w;+;+ L3 eye disc, (A) VRI-
ELAV merged image, flattened Z-sections through the photoreceptor epithelium; (B) VRI-ELAV 
merged image, single Z-section spanning the MF (white box in (A)); (C) VRI-ELAV merged 
image, flattened Z-sections through the PE; (A’, B’, C’) VRI-IR (red on merged image); (A’’, 
B’’, C’’) ELAV-IR (green on merged image) marks post-mitotic PRs. Key: anterior to the left; 
asterisk marks MF (A) scale bar = 50µm, (B) scale bar = 10µm, (C) scale bar = 50µm; minimum 
n=9. 
 
Figure 3.2C shows the peripodial epithelium (PE) of the eye disc that forms 
cuticle, VRI-IR is strong within the large nuclei of the PE. Cells of the PE and 
the antennal disc (not shown) also express the eya and so activators EY (PE 
and antennal disc) and TOY (PE) but not EYA and SO (Czerny et al., 1999; 
Halder et al., 1995; Pappu and Mardon, 2002; Pignoni et al., 1997; Bonini et 
al., 1993; Bonini et al., 1997; Punzo et al., 2002;). This suggests that another 
Chapter 3 Eye disc analysis 
63 
mechanism is necessary to prevent EYA and SO expression in those cells; be 
that in the form of a repressor in these tissues, or, that additional activators 
to EY and TOY are required in the PR epithelium. VRI expression is observed 
throughout the eye-antennal disc in L3 and appears only to be down-regulated 
ahead of the MF and hence, in the PRs as they differentiate. 
 
Pre-absorption of GP-!-VRI with lysate primed to generate full-length VRI 
protein reduces the regional expression observed in the anterior of the disc, 
though a faint background signal is still evident (Figure 3.3A). 
 
 
Figure 3.3 Pre-absorption of the primary antibody mix with in vitro synthesised VRI 
strongly reduces VRI-IR in the eye disc. w;+;+ L3 eye disc, flattened z-sections through 
entire disc, (A’) faint background staining (red on merged image, right), (A’’) ELAV-IR in PRs 
unaffected (green on merged image, right). Anterior to the left; asterisk marks MF; scale bar 
in = 50µm; minimum n=9. 
 
VRI-IR is detected in ClkJrk and cyc01 mutants in the same spatial pattern as 
w;+;+ wild-type eye discs (Figure 3.4A and 3.4B, respectively) indicating that, 
in the context of the eye disc, vri expression is driven independently of CLK-
CYC. Currently, the only known regulators of VRI are the CLK-CYC 
heterodimer (Blau and Young, 1999), this result implies that developmental 
activation of vri occurs via a CLK-CYC independent pathway.  
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Figure 3.4 VRI-IR in the L3 eye disc appears wild-type in ClkJrk and cyc01 mutants. (A) ClkJrk 
eye disc VRI-ELAV merged image, flattened z-sections through the photoreceptor epithelium; 
(B) cyc01 eye disc VRI-ELAV merged image, flattened z-sections through the photoreceptor 
epithelium. (A’, B’) VRI-IR (red on merged image, right) in the anterior eye disc; (A’’, B’’) 
ELAV-IR (green on merged image, right) marks post-mitotic PRs. Key: anterior to the left; 
asterisk marks MF; scale bar = 50µm; minimum n=9. 
 
Expression of vri, as revealed by VRI-IR, within the eye disc is dynamic and 
appears to be related to the progression of the MF. As the MF advances into 
anterior regions, VRI is down-regulated. This was best observed in discs from 
larvae of differing ages (by a matter of hours but still mid-L3 stage) and 
suggests that a reduction in VRI protein may be a cause or effect of furrow 
advancement and differentiation of PRs (Figure 3.5). 
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Figure 3.5 VRI is down-regulated ahead of the MF. Eye discs from L3 larvae at different 
stages of development, defined by the number of ELAV-positive PRs present. (A) youngest 
disc – no PRs present VRI-IR (red) throughout disc; (B) older than (A) – 1 row of PRs, VRI-IR 
down-regulated at the margin of the MF and some residual expression seen in photoreceptors; 
(C) older than (B) – 3 rows of PRs, VRI-IR further down-regulated as MF advances; ELAV-IR 
(green) marks differentiated PRs. Key: anterior to the left; asterisk marks MF; scale bar = 
50µm; minimum n=9. 
 
3.2.2 No PDP1 isoform is expressed in the L3 eye disc 
 
As PDP1# (activator) and VRI (repressor) have opposing roles in the regulation 
of Clk in the molecular oscillator mechanism (Cyran et al., 2003), and V/P 
boxes are present in eya and so loci (Chapter 4), it was possible that PDP1# 
may regulate eya and so expression during PR development. To determine if 
any of the PDP1 isoforms regulate PR development, I also checked for PDP1-IR 
in wild-type L3 eye discs. A triple immuno-labelling protocol was used and 
discs were stained for PDP1, VRI and EYA. A signal from the secondary 
fluorophore-conjugated antibody used for PDP1 labelling was apparent but 
signal distribution did not suggest cellular expression (Figure 3.6A, A’’’). 
Examining this signal through the XZ and YZ planes confirmed that the signal 
was from secondary antibody accumulation within the lumen of the discs 
(Figure 3.6B, C). VRI and EYA signals were regional as described in this study 
(VRI) and in the literature (EYA; Bonini et al., 1993) and overlap anterior to 
the MF within the PPN zone and in the ocelli precursors. 
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Figure 3.6 Orthogonal views of disc labelled for PDP1, VRI and EYA. (A) Single Z-section 
from w;+;+ eye disc XY plane; (A’, A’’, A’’’) VRI, EYA, PDP1, respectively, single channels in 
grayscale shown merged in (A). (B) single Y-section of XZ plane, apical to the top; (C) single 
X-section of YZ plane, apical to the left; (B & C) processed by Image J> Image> Stacks> 
Orthogonal views function. VRI (red) and EYA (green) labelling seen in nuclei whereas PDP1 
(blue) signal is undefined and can be seen in the lumen of the disc between the peripodial 
and photoreceptor epithelial layers. Key: anterior to the left; asterisk marks MF; scale bar = 
50µm; minimum n=9. 
 
3.2.3 VRI and EYA are expressed in partially overlapping 
regions in the L3 eye disc 
 
EYA has been described as being expressed throughout the differentiated 
photoreceptors and ahead of the furrow but not completely overlapping with 
the activators EY or TOY (Halder et al., 1998). To explore whether VRI could 
be repressing eya and so expression to prevent the observed lack of co-
expression with their activators EY and TOY, I initially immuno-labelled discs 
to see the expression of VRI and EYA in relation to one another. SO anti-serum 
is scarce and was unavailable to me therefore co-labelling of VRI and SO was 
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not carried out but EYA and SO have been reported to be expressed in the 
same cells of the developing eye disc (Pignoni et al., 1997). Co-labelling of L3 
eye discs for VRI and EYA reveals overlap in the distribution of the two 
proteins. Overlapping expression was observed in a few rows of cells anterior 
to the MF – PPN zone and in some cells of the ocellar region (Figure 3.6, 
Figure 3.7). Within the region anterior to the furrow and in the ocelli 
precursors, strong IR for both proteins was seen. 
 
 
Figure 3.7 VRI- and EYA- IR in regions of the eye disc. (A) Flattened Z-sections through 
photoreceptor region of a CS L3 eye disc; (A’, A’’) VRI-IR, EYA-IR, respectively, single 
channels in grayscale shown merged in (A). Key: anterior to the left; dorsal is top; asterisks 
mark MF; arrows point to ocellar region; scale bar in = 50µm; minimum n=9. 
 
3.2.4 Mis-expression of VRI in the photoreceptor epithelium 
 
3.2.4.1 Eye disc phenotypes 
Overlap in VRI and EYA expression suggests either, that VRI does not affect 
eya expression, or, that VRI may modulate eya expression but that multi-
factorial rather than binary interactions are taking place within this tissue. I 
decided to over-express VRI in cells after it is normally down-regulated, 
specifically, cells posterior to the MF, to see whether this would disrupt eya 
expression in the eye disc. The GMR-Gal4 driver (Freeman, 1996; Ellis et al., 
1993) was used to mis-express VRI in cells within and posterior to the MF. The 
GMR (glass multimer reporter) driver consists of a pentameric repeat of a 29-
bp region of an enhancer of the rhodopsin 1 gene (rh1/ ninaE; Ellis et al., 
1993; Moses and Rubin, 1991) bound by the GLASS transcription factor. In 
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developing eye discs, GLASS is expressed within the MF and all cells posterior 
to the MF. As EYA is also expressed in cells within and posterior to the MF, 
ectopic expression of VRI in these cells will indicate whether VRI can repress 
the expression of eya. 
 
Two different UAS-vri transgenes (different insertions) were mis-expressed 
either, alone, or, in combination with UAS-nuclear-GFP (UAS-nGFP – GFP with 
nuclear translocation signal sequences) using GMR-Gal4. GFP was used to 
identify cells in which the driver was functional and the presence or absence 
of GFP did not appear to affect the over-expression of VRI. Figures 3.8-10 
show representative eye discs in which GMR-Gal4 drives expression of UAS-
nGFP alone (Figure 3.8), or, together with UAS-vri-2b (Figure 3.9) or UAS-vri-3 
(Figure 3.10). Single Z-sections of the disc are shown as individual channels 
for VRI, EYA and GFP (Figures 3.8-10, A’, A’’, A’’’, respectively) together with 
the merged image in Figures 3.8-10 A. Merged images of all pair-wise 
combinations of channels are also shown for comparison between the figures, 
Figures 3.8-10 B’, B’’, B’’’. Although both transgenes are strongly induced by 
GMR-Gal4, expression from the UAS-vri-3 insert is somewhat stronger than 
UAS-vri-2b. 
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Figure 3.8 Activity of GMR-Gal4 highlighted by expression of UAS-nGFP transgene. (A) 
Single Z-section of disc immuno-labelled for VRI (A’, red in A) and EYA (A’’, green in A) with 
GFP expression (A’’’, blue in A) in cells in which GMR-Gal4 is active. (B’, B’’, B’’’) two 
channel merge images of individual channels shown in A’-A’’’, VRI-IR, red and EYA-IR, green 
(B’); EYA-IR, green and GFP, red(B’’); VRI-IR, red and GFP, green (B’’’). Key: anterior to the 
left; asterisk marks MF; arrows point to ocellar region; dotted line on (A) indicates edge of 
disc folded over; scale bar = 50µm; minimum n=9. 
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Figure 3.9 GMR-Gal4 driven expression of UAS-vri-2b. (A) Single Z-section of disc immuno-
labelled for VRI (A’, red in A) and EYA (A’’, green in A) with GFP expression (A’’’, blue in A) 
in cells in which GMR-Gal4 is active. (B’, B’’, B’’’) two channel merge images of individual 
channels shown in A’-A’’’, VRI-IR, red and EYA-IR, green (B’); EYA-IR, green and GFP, 
red(B’’); VRI-IR, red and GFP, green (B’’’). Key: anterior to the left; asterisk marks MF; 
arrows point to ocellar region; scale bar = 50µm; minimum n=9. 
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Figure 3.10 GMR-Gal4 driven expression of UAS-vri-3. (A) Single Z-section of disc immuno-
labelled for VRI (A’, red in A) and EYA (A’’, green in A) with GFP expression (A’’’, blue in A) 
in cells in which GMR-Gal4 is active. (B’, B’’, B’’’) two channel merge images of individual 
channels shown in A’-A’’’, VRI-IR, red and EYA-IR, green (B’); EYA-IR, green and GFP, 
red(B’’); VRI-IR, red and GFP, green (B’’’). Key: anterior to the left; asterisk marks MF; 
arrows point to ocellar region; scale bar = 50µm; minimum n=9. 
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Although expressed at a high level within the differentiating cells, induction 
of VRI by the GMR driver does not completely reduce EYA-IR and expression of 
EYA remains at a high level. However, some heterogeneity was observed in 
the extent of co-localisation of VRI and EYA within post-mitotic neurones. As 
PRs differentiate, they move apically from the basal pool of cells and start to 
form clusters in the positions and orientations that they will assume in the 
developed ommatidia (Voas et al., 2004). The PRs within each individual 
ommatidium are a heterogenous group and some of the cells of the cluster 
show both, VRI-IR and EYA-IR whilst others show only EYA-IR. Basal to the 
organised clusters, nuclear staining can be described to be of three types, (1) 
EYA-IR alone (green signal); (2) VRI- and EYA- IR at approximately equal levels 
(assessed subjectively – yellow signal); or, (3) have a greater amount of VRI-IR 
than EYA-IR (again, subjective assessment – orange signal). Finally the basal 
cell pool nuclei are predominantly of type 3 (VRI>EYA) with some nuclei of 
type 1 (EYA). These differences from apical to basal nuclei were observed for 
both UAS-vri transgenes although UAS-vri-3 was expressed in many more cells 
and at a higher level. For both transgenes, apically, large nuclei of type 3 
(VRI>EYA) staining near the MF are observed that do not seem to follow any 
specific organisation. Next, basally to these, the position of type 2 (VRI=EYA) 
staining suggests nuclei of the PRs R3 and R4 interspersed with type 1 (EYA) 
stained nuclei. More basal layers consist of increasing numbers of type 3 
(VRI>EYA) stained nuclei interspersed with more type 1 (EYA) than type 2 
(VRI=EYA) stained nuclei. VRI is more widely expressed in apical nuclei when 
induced from the UAS-vri-3 transgene with an increase in the number of type 
2 (VRI=EYA) staining nuclei to more PRs of the cluster and pre-cluster. 
 
3.2.4.2 Pupal phenotypes 
Szuplewski et al., (2003) found that over-expression of VRI using ey-Gal4 in 
the eye disc from embryonic stages caused eye deformities of varying severity 
depending on the UAS-vri transgene used. The most severe of these eye 
phenotypes was loss of the compound eye and CNS. Similarly, I have found 
that mis-expression of VRI within the PR epithelium using GMR-Gal4 caused 
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deformities of the eye of varying severity depending on whether UAS-vri-2b or 
UAS-vri-3 was used. 
 
GLASS protein is expressed within the CNS in addition to pre- and post- 
mitotic cells of the eye disc (Ellis et al., 1993). The GMR-Gal4 driver contains 
a pentameric repeat of a 29bp element of an enhancer of rh1 that is 
recognised by GLASS (Freeman, 1996; Ellis et al., 1993; Moses and Rubin, 
1991). Wernet et al (2003) generated a “long” version of GMR-Gal4 – a 
pentameric repeat of a 38bp element of the rh1 enhancer that is also 
recognised by GLASS. The long-GMR construct exhibits a higher PR specificity 
and, therefore, presumably also contains repression sites. The long-GMR 
construct, hereafter referred to as G-long, was also used to reduce non-eye-
specific VRI expression, compared to GMR-Gal4, in an attempt to rescue the 
lethal phenotype observed with GMR-Gal4. Despite spatially restricted 
expression of VRI by G-long-Gal4, eye phenotypes and pupal lethality were 
observed; however, eye phenotypes are weaker compared to those observed 
with GMR-Gal4. 
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Figure 3.11 Normally developing control animals. Pupae containing a single copy of the 
transgene indicated on the left. (A, B, I, J, N-P) 2 day old pupae; (C-H, K-M, P-R) 3-4 day old 
pupae. (I, J) green arrowheads indicate background phenotypes of GMR-Gal4 flies, necrosis 
can be seen at the wing hinge (I), or, ventral wing blade (J). Key: left panels show dorsal 
view; middle panels show ventral view; right panels show lateral view; anterior to the left. 
 
Control pupae, containing a single copy of either, Gal4 driver or UAS-vri 
responder, are shown in Figure 3.11 and appear wild-type apart from 
variation in eye colour (due to variation in the mini-white transgenic selection 
gene and normal sex differences) and some GMR-Gal4 wing phenotypes (see 
Figure legend). Control flies developed and emerged normally; experimental 
animals, however, were only observed as pharate adults extracted from 
pupae as VRI mis-expression resulted in 100% pupal lethality, irrespective of 
driver or responder line used. Similar eye phenotypes, though less severe, 
accompanied by 100% pupal lethality also resulted by raising animals at 18ºC 
to slow development. Experimental pupae of a Gal4 driver expressing UAS-vri-
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2b or UAS-vri-3 are shown in Figures 3.12 and 3.13, respectively; phenotypes 
were similar although UAS-vri-3 caused more potent and severe phenotypes. 
Black necrotic tissue within the compound eye field is observed; this ranged 
from weaker phenotypes of individual scattered ommatidia (black spots within 
a developed compound eye, Figure 3.12I), to the most severe GMR-Gal4 
mediated UAS-vri-3 phenotype causing more wide-spread necrosis and 
collapse of the cephalic region. Severity of phenotypes ranged thus: GMR-vri-3 
> GMR-vri-2b > G-long-vri-3 > G-long-vri-2b. 
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Figure 3.12 Mis-expression of the vri-2b transgene. Shorthand of genotype is indicated on 
the left. (A-C, G-I) 2 day old pupae; (D-F, J-L) 3-4 day old pupae. (A-F, I-L) Green arrowheads 
indicate necrotic eye tissue; (C) blue arrow points to collapse of cephalic region; (D) blue 
arrow points to thorax phenotype (non-eye phenotype of GMR-Gal4 widespread expression). 
Right panels, (C) dorsal view; (F) ventral view, head and upper thorax; (I) lateral view, head 
and upper thorax; (L) dorsal view, head and upper thorax. Key: left panels show dorsal view; 
middle panels show ventral view; anterior to the left. 
 
 
Figure 3.13 Mis-expression of the vri-3 transgene. Shorthand of genotype is indicated on 
the left. (A-F) 2 day old pupae; (G-K) 3-4 day old pupae. (A-C, F, G, I-K) Green arrowheads 
indicate necrotic eye tissue; (H, J) white arrowheads indicate non-eye necrotic tissue. Right 
panels, (C) dorsal view, head; (F) dorsal view, right compound eye; (I-K) lateral view of eye 
increasing in severity of phenotype. Key: left panels show dorsal view; middle panels show 
ventral view; anterior to the left. 
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3.3 Discussion 
 
3.3.1 VRI is required in the eye disc 
 
3.3.1.1 VRI as a modulator of eye development 
VRI expression was examined here in relation to the developing 
photoreceptors. Although a requirement for VRI in the eye disc had already 
been demonstrated (George and Terracol, 1997; Szuplewski et al., 2003), it 
has not been shown what function is served by VRI during eye disc 
development. I have reinforced here that VRI has a role in eye development 
that is independent of the oscillator factors CLK-CYC. In addition, it appears 
that no PDP1 isoforms are expressed within the eye disc – a further difference 
between VRI interactions as described within the oscillator mechanism, where 
VRI and PDP1 bind the same regulatory sites within the Clk gene but have 
opposing effects on gene transcription. The regional expression of VRI, which 
is expressed anterior to the MF and not within the developed PRs, appears to 
be dynamic and negatively associated with MF progression, i.e. VRI is down-
regulated ahead of MF – indicative of an acute function in MF progression and 
subsequent events. VRI is also expressed in the apposing epithelium forming 
the other side of the disc to the PR epithelium, the peripodial epithelium 
(PE). Cells of the PE form part of the cuticle and body wall and provide 
essential regulatory patterning and cell proliferation signals to the PR 
epithelium (Gibson and Schubiger, 2000; Cho et al., 2000). Cell movements 
and cell death within the PE cause contraction that eventually leads to disc 
eversion during metamorphosis (Milner et al.,1983). EY is expressed in the PE 
but EYA is not observed, either due to lack of other activators of EYA, or, 
because VRI is repressing or modulating EYA expression here. 
 
Overlap in expression of EYA and VRI ahead of the MF, in the PPN 
determination zone and the ocelli precursors, suggests that VRI does not 
repress expression of eya. However, the PPN zone ahead of the furrow shows 
convergence of many different signalling pathways – Notch, EGFR, HH, TGF" 
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(DPP), WG and the RDGN. Within this zone, convergence of signals are 
integrated and gene regulation cannot be described as ON/ OFF. If VRI is 
regulating expression of eya and so within the eye disc, it is likely that it is 
acting as a modulator. 
 
VRI as a modulator, rather than absolute repressor, is further indicated from 
the mis-expression data as VRI induction in the PRs does not act as a binary 
switch on EYA expression. Furthermore, it remains possible that there is 
perdurance of EYA protein in cells of the PR epithelium and that VRI can 
modulate the regulation of these genes even though it does not appear to be 
an absolute determinant of their expression. Alternatively, it is also possible 
that VRI induction in cells posterior to the MF cannot overcome the positive 
feedback loops established between RD genes within this region. In addition, 
evidence of different immuno-labelling types, 1 (EYA), 2 (VRI=EYA) and 3 
(VRI>EYA), suggests that VRI mis-expression in the developing PR epithelium 
does not have the same effect in all cells. The cell pool within the PR 
epithelium is heterogenous and it follows that response to mis-expression of 
VRI is heterogenous. Type 1 (EYA) cells may retain the factors that clear VRI 
protein from cells as the MF advances; type 2 (VRI=EYA) cells may have a 
more well-established positive feedback circuit for RD factors that prevent 
VRI influencing EYA expression; while type 3 (VRI>EYA) cells may represent 
cells in which VRI is able to modulate EYA moderately but not absolutely. 
Heterogeneity in VRI expression and function is also indicated by comparing 
GFP and VRI expression in the posterior eye disc. GMR-Gal4 simultaneously 
induced expression of UAS-nGFP and UAS-vri transgenes yet only partial co-
expression of GFP and VRI signals was observed – indicating uneven induction 
of these two UAS constructs. However, as similar results were observed with 
two independent inserts of UAS-vri, it is possible that cell autonomous 
mechanisms influence expression of the UAS constructs. Ultimately however, 
as in situ hybridisation data for eya and so is lacking here, suggestions of the 
action of VRI within the eye disc still require further analysis. 
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Pupal lethality resulting from mis-expression of VRI posterior to the MF with 
either, GMR-Gal4 to direct expression in all cells, or, with G-long to restrict 
expression to PRs, reiterates observations by Blau and Young (1999). 
Szuplewski et al. (2003) used ey-Gal4 to mis-express VRI within the eye disc 
from embryonic stages and observed eye phenotypes ranging in severity 
dependent on temperature and UAS-vri transgene. The most severe of these 
was absence of the eye-antennal disc in L3 larvae resulting in an absence of 
eye and other eye-antennal disc derived head structures in adult flies. Despite 
this, adult flies emerged from pupae as adults (Terracol, personal 
communication). However, there must be some remnants of eye-antennal disc 
as the organ that enables emergence from the pupal case originates from this 
disc (Cavodeassi et al., 2000). The ptilinum is an organ with a single function 
– it consists of a sac that is everted by blood pressure during eclosion to push 
open the pupal case. Following opening of the pupal case, the sac collapses 
and cuticle hardens around the area leaving the ptilinal suture (Ferris, 1994). 
That extensive damage to the eye-antennal disc using ey-Gal4 does not 
compromise viability while mis-expression of either UAS-vri transgene with 
either GMR- or G-long- Gal4 drivers causes 100% lethality during pupal stages 
suggests that off-target VRI expression causes lethality. 
 
3.3.1.2 VRI as a generic developmental factor 
Rather than be specifically a factor of eye development, it is possible that VRI 
is a developmental factor and has a generic function that is reiterated in all 
imaginal discs. VRI is expressed in wing and leg imaginal discs in addition to 
the eye-antennal disc (George and Terracol, 1997). Disruptions to VRI protein 
expression within the wing or eye-antennal discs by creating mutant clones 
causes decreases in cell size and atrophy of some cells (Szuplewski et al., 
2003). Over-expression of VRI causes atrophy in embryonic epidermis, wing 
disc and eye-antennal disc, which is attributed to an anti-proliferative 
influence as well as disrupted cytoskeletal regulation. In addition, they noted 
that similar eye phenotypes were observed by over-expressing an inhibitor of 
proliferation (Rbf) or a GTPase involved in actin cytoskeleton regulation 
(Rho1). The authors suggest that the anti-proliferative phenotype is related to 
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cytoskeletal integrity but this has not been qualified with evidence of cis-
regulatory interactions with other factors of the actin cytoskeleton network. 
 
Observations of similar phenotypes by alterations in normal VRI function 
during development raise the possibility that VRI may have a generic 
developmental role, partly in regulation of the actin cytoskeleton as 
suggested by Szuplewski et al. (2003). In such a scenario, during 
development, the primary function of VRI may be to influence general targets 
found in many cell types. In addition, VRI may also have tissue-specific targets 
that it modulates. This condition is true of several other signalling pathways 
found converging on eye development. Notch, EGFR, HH, TGF" (DPP) and WG 
all function within other imaginal discs for functions such as establishment of 
axis boundaries and antagonistic interactions, e.g. Notch and EGFR or DPP and 
WG, to act as developmental timers. It is possible that VRI is a part of this 
group of eye development factors that generate the appropriate environment 
within the tissue in order for the specific developmental factors to 
differentiate into specialized tissue. 
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Chapter 4 Binding sites and enhancer analysis 
 
4.1 Introduction 
 
4.1.1 Molecular function of VRI 
 
The bZip transcription factor protein monomers are !-helical and function as 
dimers (reviewed in Cowell, 2002; Deppmann et al., 2006). These !-helices 
bind DNA at the N-terminal and dimerise with other bZip monomers via 
repeated hydrophobic residues, particularly leucine, at the C-terminal. 
Currently, the only known function of VRI is as a homodimer in circadian 
oscillator regulation (Glossop et al., 2003). The basic DNA binding domain of 
VRI is closely related to the proline and acidic amino rich (PAR) family of bZip 
proteins but, crucially, lacks a PAR domain (Cowell, 2002). The PAR domain is 
located at the C-terminal and appears to regulate activation of genes.  
 
The 68 amino acids of the basic DNA binding domain of VRI and its human 
homologue, E4BP4/ NF-IL3A, share 60% identity and 93% similarity (George 
and Terracol, 1997). This suggested that the consensus DNA binding sequence 
for E4BP4 might assist VRI binding site searches. Indeed, the E4BP4 consensus 
sequence was used by Glossop et al. (2003) to find VRI binding sites within the 
Clk locus that were bound by VRI protein. The similarity between the DNA 
binding domains of PDP1 and VRI suggested that they may co-regulate 
(Cowell, 2002). Indeed, these sites were also shown to complex with PDP1# 
and came to be known as V/P boxes that are targeted alternatively by VRI and 
PDP1# regulation in the second feedback loop within the oscillator mechanism 
(Cyran et al., 2003). 
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4.1.2 Regulation of eya and so loci and expression at other 
developmental stages 
 
Currently the only known direct transcriptional regulator of eya is EY, initially 
identified via microarray analysis and confirmed with in silico analysis of EY 
binding sites followed by in vitro and in vivo experiments (Ostrin et al., 
2006). Regulation of so has been shown in vitro and in vivo by activtors TOY, 
EY, EYA-SO and ORTHODENTICLE (OTD; Niimi et al., 1999; Punzo et al., 2002; 
Pauli et al., 2005; Blanco et al., 2010). The majority of these interactions 
have been shown to be via an enhancer located in the sixth intron of so and 
interactions occur in a complex manner to regulate so expression during L3 
eye disc development. 
 
Embryonic expression of eya and so is observed in the developing head and 
larval CNS as well as being segmentally reiterated throughout the germ band 
as it extends and retracts (Kumar and Moses, 2001c). Only in the antero-dorsal 
region and brain lobes are eya and so co-expressed whilst germ band 
expression is in abutting domains. During larval development, EYA-IR was 
observed in the larval central brain and VNC as well as the precursors of the 
adult lamina of the compound eye (Bonini et al., 1998). In addition, 
expression was observed in the follicle cells of the ovary. Data on eya 
expression within the adult CNS is limited and EYA-IR cell clusters are 
described as functional, rather than anatomical, subsets of neurones (Bonini 
et al., 1998). Both, eya and so, are expressed within the developed adult PRs 
(Bonini et al., 1998; Serikaku and O’Tousa, 1994). There is currently no data 
on the expression of so outside of the visual system. 
 
The finding by Glossop et al., (unpublished results) that TOY is expressed in 
adult central brain oscillator cells, and enrichment of toy in oscillator cells 
(Nagoshi et al., 2010) are preliminary indications that RDGN factors have a 
role in the oscillator. eya and so expression has not been characterised with 
respect to circadian rhythms and central brain oscillator cells. Due to the 
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relationship with toy, I wanted to examine whether these genes are expressed 
within the central brain oscillator network. 
 
I show here that several potential VRI binding sites are present in eya and so 
loci. A selection of the identified sites were tested in vitro and showed 
different affinities for VRI binding, highlighting the need for validation of in 
silico analysis and revealing sites that had a high affinity for VRI protein. Two 
of these high affinity sites are located adjacent to the well-characterised 
enhancer in intron six of so and were further studied in vivo by transgenic 
reporter analysis. Further analysis revealed a modulatory role of the VRI sites 
for the enhancer. More intriguing and surprising were epistatic effects of the 
so enhancer transgene on eya expression. Larval CNS were also imaged to 
better describe the epistatic effects of the so enhancer transgene on eya 
expression. 
 
4.2 Results 
 
4.2.1 VRI binds multiple sites in the eya and so genomic loci in 
vitro 
 
Within the eya locus, 27 upstream, 2 intronic and 24 downstream V/P boxes 
were found, this equates to 53 sites within 278.5kb of DNA (exons span 
19.5kb). Contained within the so locus are 26 upstream, 2 intronic and 14 
downstream V/P boxes equating to 42 sites in 326.2kb of DNA (exons span 
15.8kb). Of these, three proximal upstream, two intronic and one downstream 
sites from eya, and two proximal and two intronic sites from so were selected 
for in vitro analysis in an electrophoretic mobility shift assay (EMSA). 
 
Figure 4.1 shows representative blots of the eya and so sites in EMSA. Lanes 1, 
2 and 3 of both the blots show identical negative (lane 1) and positive (lanes 2 
and 3) control conditions repeated in each blot. Lane 1: negative control – 
labelled probe, Clk-209, was combined with an unprimed control protein 
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synthesis lysate. Some minor background binding to lysate proteins (low 
intensity signal smear below VRI-shift position) is observed but VRI-shift is 
absent. Lane 2: positive control where labelled Clk-209 probe was combined 
with VRI-primed protein synthesis lysate, a large amount of probe is bound by 
VRI protein and is retarded higher in the gel seen as a prominent band of 
staining in the blot (VRI-shift position is indicated). Lane 3: positive control 
for competition assay represents maximal competition, unlabelled positive 
control probe was used in addition to the components used for lane 2. Used at 
an excess, the unlabelled probe displaces the labelled probe for VRI binding, 
consequently reducing the VRI shift signal. For all other lanes of the image, a 
reduction of signal at the VRI-shift position indicates that the site is bound by 
VRI. The reduction in VRI-shift is to varying degrees and is a qualitative 
indicator of affinity of VRI for the tested probe. Presence of a VRI-shift signal 
comparable to that observed in lane 2 indicates that the tested probe is not 
recognised by VRI protein. 
 
All sites from eya and so were used in a competition assay against Clk-209 and 
were named as e[x] for sites from eya or s[x] for sites from so. Figure 4.1 
shows that sites e1, e2 and e5 (lanes 4, 5 and) are able to bind VRI at an 
affinity comparable to Clk-209; site e3 shows incomplete displacement of 
labelled Clk-209 (lane 7); whilst sites e4 and e6 appear to be weak, or unable 
to, compete with Clk-209 for VRI occupancy (lanes 8 and 11). Mutation of the 
core bases of the VRI recognition site greatly reduces, or eliminates, 
competition with Clk-209 for VRI binding. Sites that were bound well by VRI, 
e2 and e5, were thus used as mutated versions (compare lanes 5 and 6, and 9 
and 10, respectively). This demonstrates that it is the specific sequence of 
the core 8 bases of the binding site that mediates the VRI-shift. 
 
Figure 4.1 shows that sites s2, s3 and s4 (lanes 5, 6 and 8) bind VRI at an 
affinity comparable to Clk-209 whereas site s1 (lane 4) only partially displaces 
Clk-209 from the VRI binding site. As observed for probes from the eya locus, 
mutation of the sequence of the core eight bases of the VRI binding site to 
non-consensus renders the probes unable to displace Clk-209 from VRI. This 
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was carried out for sites s3 and s4, (compare lanes 6 and 7, and 8 and 9, 
respectively) demonstrating again that the specific sequence of those eight 
bases of the oligonucleotide probes determines affinity for VRI. 
 
In summary, VRI has high affinity for six of the ten tested sites, reduced 
affinity for two of the sites and, very low to no affinity for two sites in the 
order: Clk-209 = e1 = e2 = e5 > e3 > e4 = e6; and Clk-209 = s2 = s3 = s4 > s1. 
Mutating bases within the binding site to form a non-consensus sequence 
abolishes binding, demonstrating that the specific sequence of a double-
stranded oligonucleotide probe is necessary for binding. Furthermore, a trend 
can be seen with regards to binding site affinity, summarised in Table 4.1. 
Sites e3-e6, s1 and s2 all contain non-consensus bases. Of these, e5 and s2 
(that compete for VRI binding comparable to control) have an identical 
sequence where the bases that can differ, or ‘wobble’, of the site are A-T-
T----A, the terminal A being non-consensus (emboldened and underlined). 
Wobble bases of e3 are T-T-T----A, and of s1 are T-G-T----G, both sites 
that show reduced competition with the positive control, s1 being the weaker 
competitor of the two. The wobble bases of sites that were not bound by VRI, 
e4 and e6, were T-G-T----A. The affinity for VRI binding to this selection of 
sites may be described: Clk-209 = e5 = s2 > e3 > s1 > e4 = e6. Sites with non-
consensus nucleotide A at the +5 position retain high affinity binding to VRI in 
combination with nucleotide T (consensus) at the -5 position (e5, s2). 
Combination of non-consensus A at the +5 position with consensus T at the -5 
position reduces affinity for VRI (e3). Further changing the e3 binding site to 
incorporate consensus nucleotide G at position -3 results in an apparent loss 
of VRI binding (e4, e6). The loss of DNA-VRI complex formation observed for 
sites e4 and e6 can be recovered to a small extent by changing the +5 position 
nucleotide to non-consensus G (s1). As single nucleotide changes of wobble 
bases of the binding site sequence changed the affinity of VRI for the site, the 
approach used here is supported. Searching for the core eight bases of the 
E4BP4/ NF-IL3A consensus binding site provides a large number of candidates 
but these require validation in EMSA. 
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Table 4.1 Summary of VRI binding to sites from eya and so. Sites for EMSA were short-listed 
by searching for the core 8 bases of the consensus binding site (combinations of consensus 
sequence possible for nucleotides at position -4 to +4). Also described is competition of these 
sites in comparison to the positive control; > indicates somewhat reduced competition; >> 
indicates considerably reduced/ absent competition. 
Probe Site sequence 
 
<  - > < +  > 
5 4321:1234 5 
Binding compared to Clk-209 (C) 
Consensus 
site 
G 
   T T      T T T A :GTAA     G C      C A 
 
C G TTAT:GTAA T Self-competition shows highest 
reduction in VRI-shift 
e1 T TTAT:GTAA C Equivalent to C 
e2 G TTAT:GTAA T Equivalent to C 
e3 T TTAT:GTAA A C > e3 
e4 T TGAT:GTAA A C >> e4 ! no binding 
e5 A TTAT:GTAA A Equivalent to C 
e6 T TGAT:GTAA A C >> e6 ! no binding 
s1 T TGAT:GTAA G C > s1 
s2 A TTAT:GTAA A Equivalent to C 
s3 T TTAT:GTAA C Equivalent to C 
s4 T TTAT:GTAA T Equivalent to C 
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Figure 4.1 EMSA results summary. TnT lysate used in binding experiments was either VRI (V in VRILLE row) or unprimed control lysate (- in VRILLE row). 
The positive control labelled probe used in all instances was from the Clk locus (C), also used unlabelled in competition assay. Competitor probes are 
described within the text. 
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4.2.2 Construction of a transgenic reporter for intron 6 of so 
 
The two VRI binding sites in the sixth intron of so were of particular interest 
as an enhancer of so has been described within this intron (Niimi et al., 1999; 
Punzo et al., 2002; Pauli et al., 2005). Since VRI is known to repress 
transcription, study of putative enhancers bearing VRI-target sites poses a 
challenge. It is possible to study such repressive enhancers either, in vitro, by 
the addition of an activation domain to VRI protein, as done by Cyran et al 
(2003); or, alternatively, by appending activatory enhancers. However, as I 
have already demonstrated that sites selected from eya and so are bound by 
VRI in vitro, I wanted to examine VRI function in vivo – and this required 
endogenous activation sites. 
 
Intron 6 of so has previously been shown to contain an enhancer element 
(Niimi et al., 1999; Punzo et al., 2002; Pauli et al., 2005) with six activation 
sites: one autoregulatory, two bound by TOY and three bound by EY and TOY. 
The enhancers bearing these sites were named as follows: so10 – a 425bp 
region containing the five PAX6 sites bound by either TOY alone or EY and 
TOY; so9 – adjacent to so10, a 1192bp region containing the autoregulatory 
site; collectively these two regions (approx. 1.6kb) were named so7. In 
addition, a recessive mutant allele of so, so1 is an eye-specific null that 
results in loss of the compound eyes and ocelli but does not affect embryonic 
so expression (Cheyette et al., 1994). This mutant results from a deletion of 
1.3kb within intron 6 that includes so10 and most of so9 (Cheyette et al., 
1994; Niimi et al., 1999). The necessity of so7 was shown by rescue of the 
eyeless, and partial rescue of the ocelli-less, phenotype by so expression 
driven by the so7 enhancer in a so1 mutant background (Punzo et al., 2002). 
In the same study partial rescue of the eyeless and ocelli-less phenotypes was 
also shown using the so10 enhancer to drive so expression in the so1 mutant 
background. Site s3 from the current study is 2300bp upstream of so7 and site 
s4 is 750bp upstream of so7, see schematic (Figure 4.2).  
 
Chapter 4 Binding sites and enhancer analysis 
89 
 
Figure 4.2 Schematic of intron 6 of so. Relative positions of the various enhancers studied 
here are shown with the positions of transcription factor binding sites indicated. The position 
of the deletion in so1 mutants is also shown. The driver lines of the so10 and so7 enhancers 
were kindly donated by W. Gehring (Niimi et al., 1999; Punzo et al., 2002; Pauli et al., 2005). 
The so7+VP enhancer driver line was generated in the current study. 
 
A region including the 2330bp (including primer upstream of s3 for cloning 
start site) upstream of so7 containing sites s3 and s4 and so7 was cloned 
upstream of Gal4 and used to make transgenic flies, henceforth referred to as 
so7+VP-Gal4. VRI binding sites within so7+VP-Gal4 were mutated to the same 
mutant sequences used for EMSA to produce the so7+VP[VP-mut]-Gal4 construct 
for a direct comparison of VRI input to this enhancer. The !C31-mediated 
site-directed transgenesis system (Bischof et al., 2007) was employed for the 
production of transgenic flies containing so7+VP-Gal4 and so7+VP[VP-mut]-Gal4. 
Site 51C located on the right arm of the second chromosome was used for 
insertion of both cloned constructs for faithful comparison. This position is 
intergenic and the neighbouring genes are 18894bp (M-spondin) upstream and 
5971bp (CG12865) downstream. CG12865 is yet to be characterised. M-
spondin is an extra-cellular matrix protein (Umemiya et al., 1997) and is 
expressed in the lamina and R7 PR (Mollereau et al., 2000). Currently, there 
are no documented background effects due to the use of this landing site for 
transgenesis. 
 
The contribution of the VRI binding sites to the intron 6 enhancer of so was 
assessed by comparison of GFP expression mediated by so7+VP-Gal4 and 
so7+VP[VP-mut]-Gal4 with so7-Gal4 and so10-Gal4 lines. 
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4.2.3 Comparison of so intron 6 transgenic lines 
 
GFP reporter and antibody labelling observed for the driver lines was 
compared to that observed in negative control animals of the genotype w; +; 
UAS-nGFP, referred to only as control animals, below. Antibody labelling 
observed in control animals is identical to that observed for wild-type animals 
apart from ectopic GFP expression within the lamina of adult CNS (Figure 
4.12, plates 1 and 2). This ectopic expression was at basal level and did not 
impact on expression observed in the presence of the drivers. 
 
4.2.3.1 Larval eye discs 
Pauli et al. (2005) described so10 as controlling expression within the 
compound eye precursor field of the eye disc but not in the ocelli precursor 
field. Meanwhile so9 was only expressed at the posterior margin of the eye 
disc. Combination of the two regions into the so7 fragment resulted in an 
expansion of so10-mediated expression into the ocelli precursor cells. 
However, so10 and so7 expression appeared to extend further past the MF and 
into anterior regions than was reported by immuno-staining protocols for SO 
(Cheyette et al., 1994; Halder et al., 1998). VRI is expressed in anterior 
regions where so7 appears to drive ectopic expression. I was interested in 
studying the differences in expression mediated by so7-Gal4 and so7+VP-Gal4 
particularly in these cells of the eye disc and PE. Together with this 
comparative analysis, it was important to assess the specific contribution of 
the VRI sites with the use of so7+VP[VP-mut]. EYA and SO function as a 
heterodimeric transactivation complex during development of the eye disc 
and their expression is described to entirely overlap one another (Bonini et 
al., 1993; Cheyette et al., 1994; Serikaku and O’Tousa, 1994). To compare 
GFP expression to endogenous regional expression and in relation to VRI 
expression, larval tissues were co-labelled with EYA and VRI antibodies. 
 
I show that so10-Gal4 expresses GFP in several groups of cells: (1) PE; (2) 
minimally within PRs although highest expression was seen in cells adjacent to 
Chapter 4 Binding sites and enhancer analysis 
91 
the MF; (3) strong expression in cells anterior to the MF. Expression in cells 
anterior to the MF extends into the lateral margins of the eye disc, this 
includes a subset of the ocelli precursors (outlined in Figure 4.3B) – medial 
cells of the dorsal group of precursors. Co-labelling for EYA whilst examining 
the expression mediated by the enhancer revealed that the so10 enhancer 
drives expression within a subset of the cells comprising the dorsal ocelli 
precursors. This explains why only partial rescue of the ocelli-less phenotype 
is observed when so10 drives so expression in a so1 mutant background (Punzo 
et al., 2002; Pauli et al., 2005). 
 
so7-Gal4 drives GFP expression in the same groups of cells but is up-
regulated. Additionally, GFP expression extends into both dorsal and ventral 
ocelli precursor cell groups but the expression in the lateral margin of the eye 
disc leading to the ocelli is down-regulated such that there is an interruption 
in GFP expression between cells just anterior the MF and the ocelli precursor 
cells. These results are consistent with earlier descriptions of so10 and so7 
enhancer activities, both of which rescued the eyeless phenotype of so1 
mutants, with so7 also partially rescuing the ocelli-less phenotype as result of 
driver activity in an increased number of cells of the lateral margin, including 
the precursors. 
 
Expression of GFP mediated by so7+VP and so7+VP[VP-mut] shows similar 
localisation but an up-regulation of GFP signal intensity mediated by 
so7+VP[VP-mut] . Compared to so7, expression within the dorso-lateral margin of 
the eye disc is increased and a greater number of the ocelli precursors show 
GFP expression. 
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Figure 4.3 Activity of so10-Gal4 in L3 eye disc reported by GFP co-labelled for VRI and 
EYA. (A) Single Z-section of PR epithelium of disc immuno-labelled for VRI (A’, red in A) and 
EYA (A’’, green in A) with GFP expression (A’’’, blue in A). (B) Single Z-section of PE of disc 
immuno-labelled for VRI (B’, red in B) and EYA (B’’, green in B) with GFP expression (B’’’, 
blue in B). (C) Flattened Z-sections of ocelli precursors (white box on A) immuno-labelled for 
VRI (C’, red in C) and EYA (C’’, green in C) with GFP expression (C’’’, blue in C). Key: anterior 
to the left; asterisk marks MF; white box on (A) shown expaned in (C); scale bar = 50µm; 
minimum n=5.  
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Figure 4.4 Activity of so7-Gal4 in L3 eye disc reported by GFP co-labelled for VRI and EYA. 
(A) Single Z-section of PR epithelium of disc immuno-labelled for VRI (A’, red in A) and EYA 
(A’’, green in A) with GFP expression (A’’’, blue in A). (B) Single Z-section of PE of disc 
immuno-labelled for VRI (B’, red in B) and EYA (B’’, green in B) with GFP expression (B’’’, 
blue in B). (C) Flattened Z-sections of ocelli precursors (white box on A) immuno-labelled for 
VRI (C’, red in C) and EYA (C’’, green in C) with GFP expression (C’’’, blue in C). Key: anterior 
to the left; asterisk marks MF; white box on (A) shown expaned in (C); scale bar = 50µm; 
minimum n=5.  
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Figure 4.5 Activity of so7+VP-Gal4 in L3 eye disc reported by GFP co-labelled for VRI and 
EYA. (A) Single Z-section of PR epithelium of disc immuno-labelled for VRI (A’, red in A) and 
EYA (A’’, green in A) with GFP expression (A’’’, blue in A). (B) Single Z-section of PE of disc 
immuno-labelled for VRI (B’, red in B) and EYA (B’’, green in B) with GFP expression (B’’’, 
blue in B). (C) Flattened Z-sections of ocelli precursors (white box on A) immuno-labelled for 
VRI (C’, red in C) and EYA (C’’, green in C) with GFP expression (C’’’, blue in C). Key: anterior 
to the left; asterisk marks MF; white box on (A) shown expanded in (C); scale bar = 50µm; 
minimum n=5.  
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Figure 4.6 Activity of so7+VP[VP-mut]-Gal4 in L3 eye disc reported by GFP co-labelled for 
VRI and EYA. (A) Single Z-section of PR epithelium of disc immuno-labelled for VRI (A’, red in 
A) and EYA (A’’, green in A) with GFP expression (A’’’, blue in A). (B) Single Z-section of PE of 
disc immuno-labelled for VRI (B’, red in B) and EYA (B’’, green in B) with GFP expression 
(B’’’, blue in B). (C) Flattened Z-sections of ocelli precursors (white box on A) immuno-
labelled for VRI (C’, red in C) and EYA (C’’, green in C) with GFP expression (C’’’, blue in C). 
Key: anterior to the left; asterisk marks MF; white box on (A) shown expanded in (C); scale 
bar = 50µm; minimum n=5.  
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4.2.3.2 Larval CNS, antennal and leg discs 
Within antennal discs, no GFP expression is observed in discs from the so10-
Gal4 driver (Figure 4.7B), as seen for discs from control animals (Figure 4.7A), 
whereas 2 or 3 cells express GFP in antennal discs from so7-Gal4 (Figure 
4.7C). For the so7+VP- and so7+VP[VP-mut]- Gal4 drivers (Figures 4.7D and 4.7E, 
respectively), cells at the attachment site of the antennal discs to the mouth 
hooks contain GFP and the number of cells and intensity of the signal 
increases in discs from so7+VP[VP-mut]-Gal4. 
 
 
Figure 4.7 Activity of so intron 6 drivers in L3 antennal disc reported by GFP and co-
labelled for VRI and EYA. Flattened Z-sections of the antennal discs of (A) control (genotype: 
w; +; UAS-nGFP); (B) so10-Gal4; (C) so7-Gal4; (D) so7+VP-Gal4; (E) so7+VP[VP-mut]-Gal4. Key: 
anterior to the left; VRI-IR (red), EYA-IR (green), GFP (blue); scale bar = 50µm; minimum n=5.  
 
Leg discs (attached to CNS, see Figures 4.8-10 of L3 CNS) of the different 
driver lines show a similar relationship compared to the antennal discs. The 
so10-Gal4 driver does not show any reporter signal whereas, GFP is expressed 
in a small number of individual cells scattered throughout the leg discs of the 
so7-Gal4 driver. For the so7+VP and so7+VP[VP-mut] drivers, the GFP expression 
is regionalised to the thoracic body wall attachment site and distal leg 
regions, once again at a higher intensity in discs from so7+VP[VP-mut] compared 
to so7+VP. 
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The most pronounced difference between transgenic constructs from this 
study and those that they were based on is that seen within the CNS of L3 
larvae. Reports on EYA expression did not describe which cells within the 
developing CNS were positive for EYA (Bonini et al., 1998) and expression 
mediated by the various so intron 6 enhancers was not described for the CNS 
(Punzo et al., 2002; Pauli et al., 2005). I found that in control L3 larval CNS, 
EYA expression is seen in cells of the outer optic anlagen; in 11 pairs of cells 
either side of the midline in the ventral nerve cord (VNC) and some cell 
groups lateral to these in the anterior VNC; and, in medial cell clusters of the 
central brain (Figure 4.8A and A’’’). EYA-IR is also observed in leg discs (still 
attached to the CNS) near the thoracic attachment and regions that form 
distal leg. This expression pattern is also observed in L3 CNS from so10- and 
so7- Gal4 driver lines (Figure 4.9A and A’’’ and 4.9C and C’’’, respectively). In 
the CNS from so7+VP-Gal4 (Figure 4.10A and A’’’), there is a clear up-
regulation of EYA expression in several additional cell groups. These include 
cells in the VNC and central brain as well as in an axonal projection extending 
into the inner optic anlagen, likely to be Bolwig’s nerve – the projection from 
the larval photoreceptive organ of the same name. An identical pattern of 
expression is observed in CNS of so7+VP[VP-mut]-Gal4 but EYA staining intensity 
is increased (Figure 4.10C and C’’’). This suggests that either, the insertion 
site used for the transgenics generated here has a trans-activation effect on 
eya expression; or, that the additional region of the so intron used for the 
driver lines is altering epistasis of eya. 
 
Meanwhile, GFP expression mediated by the driver lines is always observed in 
the outer optic anlagen with intensity and region size increasing such that 
so10 < so7 < so7+VP < so7+VP[VP-mut]. Within the central brain, a small number 
of cells express GFP driven by the so10 driver, this number increases with the 
so7 driver (compare Figure 4.9A’ and 9C’) but is suppressed by both, so7+VP 
and so7+VP[VP-mut] drivers (compare Figure 4.10A’ and C’ with Figure 4.9C’). 
Similarly, expression within the VNC is evident in a few disparate cells when 
driven by so10 (Figure 4.9A’). The number of cells increases and pattern of 
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expression of GFP extends into bilaterally symmetrical longitudinal axonal 
tracts with the so7 driver (Figure 4.9C’), reminiscent of the longitudinal 
connectives and some commissural projections are observed, but not within 
every segment. The so7+VP and so7+VP[VP-mut] drivers do not show any VNC 
expression of GFP (Figure 4.10A’ and C’). 
 
 
Figure 4.8 Control L3 CNS labelled for VRI and EYA. (A) Flattened Z-sections showing GFP 
expression (A’, blue in A) and immuno-labelled for VRI (A’’, red in A) and EYA (A’’’, green in 
A). (B’, B’’, B’’’) two channel merge images of individual channels shown in A’-A’’’: GFP, red 
and EYA-IR, green (B’); VRI-IR, red and GFP, red (B’’); VRI-IR, red and EYA-IR, green (B’’’). 
Key: dorsal to the top; OL, optic lobe; LD, leg disc; CB, central brain; VNC, ventral nerve 
cord; scale bar = 100µm; minimum n=5. 
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Figure 4.9 L3 CNS of so10-Gal4 and so7-Gal4 labelled for VRI and EYA. (A) Flattened Z-
sections showing GFP expression mediated by so10-Gal4 (A’, blue in A) and immuno-labelled 
for VRI (A’’, red in A) and EYA (A’’’, green in A). (B’, B’’, B’’’) two channel merge images of 
individual channels shown in A’-A’’’: GFP, red and EYA-IR, green (B’); VRI-IR, red and GFP, 
red (B’’); VRI-IR, red and EYA-IR, green (B’’’). (C) Flattened Z-sections showing GFP 
expression mediated by so7-Gal4 (C’, blue in C) and immuno-labelled for VRI (C’’, red in C) 
and EYA (C’’’, green in C). (D’, D’’, D’’’) two channel merge images of individual channels 
shown in C’-C’’’: GFP, red and EYA-IR, green (D’); VRI-IR, red and GFP, red (D’’); VRI-IR, red 
and EYA-IR, green (D’’’). Key: dorsal to the top; OL, optic lobe; LD, leg disc; CB, central 
brain; VNC, ventral nerve cord; scale bar = 100µm; minimum n=5. 
Chapter 4 Binding sites and enhancer analysis 
100 
 
Figure 4.10 L3 CNS of so7+VP-Gal4 and so7+VP[VP-mut]-Gal4 labelled for VRI and EYA. (A) 
Flattened Z-sections showing GFP expression mediated by so7+VP-Gal4 (A’, blue in A) and 
immuno-labelled for VRI (A’’, red in A) and EYA (A’’’, green in A). (B’, B’’, B’’’) two channel 
merge images of individual channels shown in A’-A’’’: GFP, red and EYA-IR, green (B’); VRI-IR, 
red and GFP, red (B’’); VRI-IR, red and EYA-IR, green (B’’’). (C) Flattened Z-sections showing 
GFP expression mediated by so7+VP[VP-mut]-Gal4 (C’, blue in C) and immuno-labelled for VRI 
(C’’, red in C) and EYA (C’’’, green in C). (D’, D’’, D’’’) two channel merge images of 
individual channels shown in C’-C’’’: GFP, red and EYA-IR, green (D’); VRI-IR, red and GFP, 
red (D’’); VRI-IR, red and EYA-IR, green (D’’’). Key: dorsal to the top; OL, optic lobe; LD, leg 
disc; CB, central brain; VNC, ventral nerve cord; scale bar = 100µm; minimum n=5. 
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4.2.3.3 Adult CNS at different times of the day 
The so intron 6 driver lines were also used to examine whether these 
enhancers mediate expression in the mature central brain clock cells and, if 
so, whether reporter expression changes over the course of the day. Adult 
brains were dissected at ZT3, 9, 15 and 21 and co-labelled for CLK and EYA. 
EYA has previously been reported to be expressed in the nuclei of several cells 
in the adult CNS but were not ascribed to be part of any previously described 
anatomical nuclei (Bonini et al., 1998). Rather, the distribution of EYA-
positive cells was considered to be as functional clusters that spanned 
anatomical brain regions. In addition to learning the positions of EYA-positive 
cells in relation to oscillator neurones, I was also interested to know whether 
EYA is rhythmically regulated. That there may be rhythmic regulation of EYA 
is suggested by data that indicate an involvement of TOY, an activator of EYA 
in developing eye discs, in regulation of Clk (Glossop et al., unpublished 
data). 
 
Oscillator neurones were marked using CLK-GP50 antiserum (Houl et al., 
2008). Houl et al. (2008) describe CLK-IR to be constitutive and indeed, I 
found that CLK signal is identical for all the tested genotypes and is also 
constitutively present during all four tested ZT times (Figures 4.12 and 4.14-
16, plates 1 and 2 and Figure 4.13, plate 2, A, A’’, B, B’’, D, D’’, E, E’’; 
Figure 4.13, plate 1 A, A’’, B, B’’, D, D’’, F, F’’, G, G’’). CLK was also 
detected in nuclei of glial cells that ensheathe the entire CNS, nuclei of the 
lamina monopolar neurones and the ocellar interneurones. 
 
so10>GFP was expressed in a small number of cells that had a scattered 
distribution throughout the CNS and did not co-localise with CLK- or EYA- 
positive cells (Figure 4.13, plate 1 A, A’, B, B’, D, D’, F, F’, G, G’; plate 2 A, 
A’, B, B’, D, D’, E, E’). GFP remained in the cytoplasm of some of these cells 
and spread through the processes, though morphology could not be accurately 
traced. 
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so7>GFP was present in cell bodies that lie between the lamina and the optic 
lobe (Figure 4.14, plates 1 and 2 A, A’, B, B’, D, D’, E, E’). Expression was 
robust and seen as concentrated GFP between the lamina and optic lobe. 
Within the central brain, expression was apparent in numerous cells with a 
scattered distribution, as for so10>GFP. Again, co-expression with CLK or EYA 
was not observed either. 
 
so7+VP>GFP and so7+VP[VP-mut]>GFP show identical results for GFP expression 
within the adult CNS (Figures 4.15 and 4.16, plates 1 and 2, A, A’, B, B’, D, 
D’, E, E’). Compared to so7>GFP, GFP is down-regulated in the central brain 
and up-regulated in the lamina monopolar cells and their processes. 
 
In addition, as in the larval CNS, ectopic expression of EYA is seen in scattered 
neurones of the central brain (similar to so7>GFP expression); in the ocellar 
interneuronal nuclei and axons; and, in axons of the visual system (Figures 
4.12 and 4.14-16, plates 1 and 2 and Figure 4.13, plate 2, A, A’’’, B, B’’’, D, 
D’’’, E, E’’’; Figure 4.13, plate 1 A, A’’’, B, B’’’, D, D’’’, F, F’’’, G, G’’’). 
Visual system axons include the Hofbauer-Buchner tract and other 
photoreceptor axons from, either, lamina interneurones between R1-R6 and 
the medulla, R7 and R8 direct projections to the medulla, or both. 
 
The Hofbauer-Buchner tract (H-B tract) contains the axonal projection from 
the Hofbauer-Buchner eyelet (H-B eyelet), which is an extra-retinal, extra-
ocular ‘eyelet’ that lies below the posterior margin of the compound eye and 
is formed during metamorphosis from the remnant of Bolwig’s organ, the 
larval photoreceptive organ (Helfrich-Förster et al., 2002). The H-B eyelet 
retains the photopigment Rhodopsin 6 (Rh6) and projection pattern of 
Bolwig’s organ which has arborisations near the sLNvs. During metamorphosis, 
the l-LNvs differentiate and the H-B eyelet also arborises with these. Bolwig’s 
organ is the only opsin-mediated photoreceptor in larvae and (Xiang et al., 
2010), together with cryptochrome, provides photic information to sLNvs for 
circadian rhythmicity in larvae (Malpel et al., 2002). The eyelet’s contribution 
in the adult is more complex as photic information for entrainment of the 
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LNvs for circadian rhythmicity is also provided by the compound eyes in 
addition to eyelet and cryptochrome (Helfrich-Förster et al., 2001). 
 
Endogenous EYA expression was not observed in afferent innervations to the 
optic lobes of control, so10>GFP or so7>GFP adult brains at any of the time 
points analysed. This was confirmed by increasing the laser power to 
maximum in order to reveal whether the extra EYA signal seen in so7+VP>GFP 
and so7+VP[VP-mut]>GFP was an up-regulation of normal protein distribution 
that is usually below analysis threshold (data not shown). The normal 
distribution of EYA was nuclear and observed in control, so10>GFP and 
so7>GFP CNS, and which persisted in so7+VP>GFP and so7+VP[VP-mut]>GFP lines; 
cells are categorised into five clusters within the central brain according to 
their anatomical location. I have labelled these clusters EYA+ve 1-5 and their 
positions relative to oscillator neurones are shown on Figure 4.12. EYA+ve 1, a 
large cluster of >40 cells in the posterior dorsal superior protocerebrum 
distributed amongst the DN1s and DN2s. EYA+ve 2, a large cluster of >40 cells 
in the lateral dorsal brain ventral to DN3s. EYA+ve 3, a large cluster of 20-30 
cells in the anterior lateral ventral brain clustered from the LNds to the LNvs. 
EYA+ve 4, 3-5 cells close to the midline in the posterior dorso-medial superior 
protocerebrum. EYA+ve 5, 6 cells in the posterior ventro-medial brain. The 
EYA+ve 1 and 2 clusters were also described by Bonini et al. (1998). The 
central body neuropiles of fan-shaped body, ellipsoid body and noduli 
appeared to show EYA-IR although signal is not nuclear and does not show cell 
shape definition, rather, it is suggestive of background staining. 
 
Two cells of the EYA+ve 1 group are co-labelled for CLK in all genotypes at all 
tested times of the day and their position indicates that they are the DN2s. In 
addition, one of the EYA+ve 2 cells sometimes co-labels for CLK and appears 
to be a large DN3. The heterogeneous DN3 oscillator neurone group consists of 
large and small cells that extend from posterior into anterior regions. 
Although this co-labelled EYA+ve 2 cell was seen within each genotype at 
each time-point, there was some inconsistency. The position of this cell 
within the DN3 group was always lateral but seen variously in an anterior or 
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posterior position and sometimes could not be distinguished from the 
surrounding cells.  
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Figure 4.11 EYA and oscillator gene expressing cells in the adult Drosophila brain. Figure adapted from Helfrich-Förster (2003), left hemisphere of image has 
been faded in order to superimpose groups of cells showing EYA-IR from the current study (EYA+ve 1-5, represented by different colours for cells comprising 
individual groups). Dashed line box indicates optic lobe region shown in figures 4.12, 4.13 plate 2 and 4.14-4.16 A and D, figure 4.13 plate 1 A and F. Dotted line 
box indicates central brain region shown in figures 4.12, 4.13 plate 2 and 4.14-4.16 B and E, figure 4.13 plate 1 B, D and G. Original image maintained for the 
right hemisphere showing the oscillator neurone groups of the central brain: lateral neurons (LNd, LPN, l-LNv, s-LNv); dorsal neurons (DN1, DN2, DN3); R1-6: 
nuclei from photoreceptor cells 1 to 6, R7/8: nuclei from photoreceptor cells 7 and 8; H-B: photoreceptor cells of the Hofbauer-Buchner eyelets); glia shown as 
distributed pink cells. 
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Figure 4.12, Plate 1 Wild-type control (w;+;+/UAS-nGFP) adult CNS at ZT3 and ZT9. Minimum n=3 each, male and female; full legend on page 116. 
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Figure 4.12, Plate 2 Wild-type control (w;+;+/UAS-nGFP) adult CNS at ZT15 and ZT21. Minimum n=3 each, male and female; full legend on page 116. 
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Figure 4.13, Plate 1 so10-Gal4 adult CNS at ZT3 and ZT9. Minimum n=3 each, male and female; full legend on page 116. 
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Figure 4.13, Plate 2 so10-Gal4 adult CNS at ZT15 and ZT21. Minimum n=3 each, male and female; full legend on page 116. 
Chapter 4 Binding sites and enhancer analysis 
110 
 
Figure 4.14, Plate 1 so7-Gal4 adult CNS at ZT3 and ZT9. Minimum n=3 each, male and female; full legend on page 116. 
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Figure 4.14, Plate 2 so7-Gal4 adult CNS at ZT15 and ZT21. Minimum n=3 each, male and female; full legend on page 116. 
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Figure 4.15, Plate 1 so7+VP-Gal4 adult CNS at ZT3 and ZT9. Minimum n=3 each, male and female; full legend on page 116. 
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Figure 4.15, Plate 2 so7+VP-Gal4 adult CNS at ZT15 and ZT21. Minimum n=3 each, male and female; full legend on page 117. 
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Figure 4.16, Plate 1 so7+VP[VP-mut]-Gal4 adult CNS at ZT3 and ZT9. Minimum n=3 each, male and female; full legend on page 117. 
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Figure 4.16, Plate 2 so7+VP[VP-mut]-Gal4 adult CNS at ZT15 and ZT21. Minimum n=3 each, male and female; full legend on page 117. 
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Figures 4.12-16 Adult brains expressing GFP and immuno-labelled for CLK and EYA. Plate 
1 shows ZT3 and ZT9, Plate 2 shows ZT15 and ZT21. Left hemisphere of brain, midline is to 
the right and dorsal top, slight deviations of orientation of CNS are shown by representation 
of axes. Key: (D – V, dorsal ventral; L – M, lateral medial); circled cells are co-labelled for CLK 
and EYA; OL, optic lobe; L, lamina; ONs, ocellar interneurones; ON-I – ocellar interneuronal 
tract; H-Bt – Hofbauer-Buchner tract; DN1s, DN2s, DN3s, LNds, LPNs, lLNVs, sLNVs, – oscillator 
neurone groups; XR, cross-reactivity of donkey anti-guinea pig-Cy5 secondary antibody to 
SLOB neurones; scale bars are 50µm; minimum n=3 each, male and female. 
 
Figure 4.12, Panel 1 Wild-type control w;+;+/UAS-nGFP A – C’’’, (ZT3); D – F’’’, (ZT9). (A 
and D) Flattened Z-sections of optic lobe with some attached lamina (A only); individual 
channels for GFP (A’, D’), CLK (A’’, D’’) and EYA (A’’’, D’’’) also shown. (B, E) Flattened Z-
sections of dorsal central brain with ocellar interneurones attached (E only); individual 
channels for GFP (B’, E’), CLK (B’’, E’’) and EYA (B’’’, E’’’) also shown. (C’-C’’’ and F’-F’’’) 
two channel merge images of individual channels shown in B’-B’’’ or E’-E’’’, respectively. 
 
Figure 4.12, Panel 2 Wild-type control w;+;+/UAS-nGFP A – C’’’, (ZT15); D – F’’’, (ZT21). (A 
and D) Flattened Z-sections of optic lobe with some attached lamina (D only); individual 
channels for GFP (A’, D’), CLK (A’’, D’’) and EYA (A’’’, D’’’) also shown. (B, E) Flattened Z-
sections of dorsal central brain with ocellar interneurones attached (E only); individual 
channels for GFP (B’, E’), CLK (B’’, E’’) and EYA (B’’’, E’’’) also shown. (C’-C’’’ and F’-F’’’) 
two channel merge images of individual channels shown in B’-B’’’ or E’-E’’’, respectively. 
 
Figure 4.13, Panel 1 so10-Gal4 A – E’’’, (ZT3); F – H’’’, (ZT9). (A and D) Flattened Z-sections 
of optic lobe with some attached lamina (F only); individual channels for GFP (A’, F’), CLK 
(A’’, F’’) and EYA (A’’’, F’’’) also shown. (B, D, E) Flattened Z-sections of dorsal central brain 
with ocellar interneurones attached (B, D only); anterior (B) and posterior (D) of the same 
CNS; individual channels for GFP (B’, D’, G’), CLK (B’’, D’’, G’’) and EYA (B’’’, D’’’, G’’’) also 
shown. (C’-C’’’, E’-E’’’ and H’-H’’’) two channel merge images of individual channels shown 
in B’-B’’’, D’-D’’’ or G’-G’’’, respectively. 
 
Figure 4.13, Panel 2 so10-Gal4 A – C’’’, (ZT15); D – F’’’, (ZT21). (A and D) Flattened Z-
sections of optic lobe with some attached lamina (A only); individual channels for GFP (A’, 
D’), CLK (A’’, D’’) and EYA (A’’’, D’’’) also shown. (B, E) Flattened Z-sections of dorsal 
central brain with ocellar interneurones attached (E only); individual channels for GFP (B’, 
E’), CLK (B’’, E’’) and EYA (B’’’, E’’’) also shown. (C’-C’’’ and F’-F’’’) two channel merge 
images of individual channels shown in B’-B’’’ or E’-E’’’, respectively. 
 
Figure 4.14, Panel 1 so7-Gal4 A – C’’’, (ZT3); D – F’’’, (ZT9). (A and D) Flattened Z-sections 
of optic lobe with some attached lamina (A only); individual channels for GFP (A’, D’), CLK 
(A’’, D’’) and EYA (A’’’, D’’’) also shown. (B, E) Flattened Z-sections of dorsal central brain 
with ocellar interneurones attached (E only); individual channels for GFP (B’, E’), CLK (B’’, 
E’’) and EYA (B’’’, E’’’) also shown. (C’-C’’’ and F’-F’’’) two channel merge images of 
individual channels shown in B’-B’’’ or E’-E’’’, respectively. 
 
Figure 4.14, Panel 2 so7-Gal4 A – C’’’, (ZT15); D – F’’’, (ZT21). (A and D) Flattened Z-
sections of optic lobe with some attached lamina; individual channels for GFP (A’, D’), CLK 
(A’’, D’’) and EYA (A’’’, D’’’) also shown. (B, E) Flattened Z-sections of dorsal central brain 
with ocellar interneurones attached; individual channels for GFP (B’, E’), CLK (B’’, E’’) and 
EYA (B’’’, E’’’) also shown. (C’-C’’’ and F’-F’’’) two channel merge images of individual 
channels shown in B’-B’’’ or E’-E’’’, respectively. 
 
Figure 4.15, Panel 1 so7+VP-Gal4 A – C’’’, (ZT3); D – F’’’, (ZT9). (A and D) Flattened Z-
sections of optic lobe with some attached lamina (D only); individual channels for GFP (A’, 
D’), CLK (A’’, D’’) and EYA (A’’’, D’’’) also shown. (B, E) Flattened Z-sections of dorsal 
central brain with ocellar interneurones attached; individual channels for GFP (B’, E’), CLK 
(B’’, E’’) and EYA (B’’’, E’’’) also shown. (C’-C’’’ and F’-F’’’) two channel merge images of 
individual channels shown in B’-B’’’ or E’-E’’’, respectively. 
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Figure 4.15, Panel 2 so7+VP-Gal4 A – C’’’, (ZT15); D – F’’’, (ZT21). (A and D) Flattened Z-
sections of optic lobe with some attached lamina; individual channels for GFP (A’, D’), CLK 
(A’’, D’’) and EYA (A’’’, D’’’) also shown. (B, E) Flattened Z-sections of dorsal central brain 
with ocellar interneurones attached; individual channels for GFP (B’, E’), CLK (B’’, E’’) and 
EYA (B’’’, E’’’) also shown. (C’-C’’’ and F’-F’’’) two channel merge images of individual 
channels shown in B’-B’’’ or E’-E’’’, respectively. 
 
Figure 4.16, Panel 1 so7+VP[VP-mut]-Gal4 A – C’’’, (ZT3); D – F’’’, (ZT9). (A and D) Flattened 
Z-sections of optic lobe with some attached lamina; individual channels for GFP (A’, D’), CLK 
(A’’, D’’) and EYA (A’’’, D’’’) also shown. (B, E) Flattened Z-sections of dorsal central brain 
with ocellar interneurones attached; individual channels for GFP (B’, E’), CLK (B’’, E’’) and 
EYA (B’’’, E’’’) also shown. (C’-C’’’ and F’-F’’’) two channel merge images of individual 
channels shown in B’-B’’’ or E’-E’’’, respectively. 
 
Figure 4.16, Panel 2 so7+VP[VP-mut]-Gal4 A – C’’’, (ZT15); D – F’’’, (ZT21). (A and D) 
Flattened Z-sections of optic lobe with some attached lamina; individual channels for GFP 
(A’, D’), CLK (A’’, D’’) and EYA (A’’’, D’’’) also shown. (B, E) Flattened Z-sections of dorsal 
central brain with ocellar interneurones attached; individual channels for GFP (B’, E’), CLK 
(B’’, E’’) and EYA (B’’’, E’’’) also shown. (C’-C’’’ and F’-F’’’) two channel merge images of 
individual channels shown in B’-B’’’ or E’-E’’’, respectively. 
 
4.3 Discussion 
 
4.3.1 VRI binding sites at the eya and so loci 
 
The sequence used for VRI-binding assays is based on that reported for E4BP4/ 
NF-IL3A (Cowell et al., 1992), as VRI E4BP4/ NF-IL3A is 60% identical, equating 
to 93% similarity, over 68 amino acids of the DNA-binding, basic domain 
(George and Terracol, 1997). This site has previously been shown to be bound 
by VRI and is dependent on the intact basic domain (Glossop et al., 2003). 
Although Glossop et al., (2003) successfully used the E4BP4/ NF-IL3A binding 
site as basis for their work, it remains possible that there are small 
differences between DNA sequence recognition by VRI and E4BP4/ NF-IL3A. 
For this reason, the -5 and +5 positions of the binding site were not used for 
data mining. This strategy combined with determination of site recognition by 
VRI using EMSA revealed that VRI is indeed able to bind some sequences that 
are non-consensus at bases -5 and/or +5.  
 
Discovery of several sites potentially recognised by VRI is suggestive of direct 
regulation of these genes by VRI, however, only a few sites were analysed. 
The sites selected for further analysis were those in closest proximity to 
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coding regions of the gene and, although enhancers may be found at great 
distances from the genes they regulate (reviewed by Levine, 2010), for this 
preliminary work, only these proximal sites were considered for further study. 
 
4.3.2 Intron 6 of so contains a novel enhancer region – is VRI 
also involved? 
 
A spontaneous mutation, so1, has a deletion of 1.3kb within the sixth intron of 
so and results in loss of the compound eyes and ocelli (Cheyette et al., 1994). 
At the time this work commenced, EY, TOY and SO were reported to regulate 
expression of so for the development of the adult visual system through 
interactions with the region of intron six deleted in so1 mutants (Niimi et al., 
1999; Punzo et al., 2002; Pauli et al., 2005). Using transgenic reporters and in 
vitro assays, this eye-specific enhancer (so7) was shown to be bound at five 
sites by TOY, three of those sites could also be recognised by EY and a sixth 
site was bound SO for autoregulation. Moreover, these regions induced 
reporter expression in the presumptive eye field and rescued the compound 
eye phenotype and partially rescued the ocelli-less phenotype. 
 
The presence of six activators in close proximity to sites s3 and s4, here 
hypothesised to be bound by the negative regulator VRI, allows study of the 
normal regulatory region in transgenic flies. Although very useful for certain 
paradigms, EMSAs or in vitro assays using luciferase reporters in cell cultures 
are not accurate representations of in vivo relationships. In the case of cell 
cultures, the combination of factors present is different to that found 
endogenously and may generate false positives. Naturally, transgenic driver-
reporter systems (Brand and Perrimon, 1993) have their limitations also – 
position effect variegation being the primary factor that may affect results, 
yet it remains one of the gold-standard techniques available for Drosophila 
research. Therefore, I used transgenic reporter analysis for studying variations 
of the enhancer located in intron six of so for assessing the influence of VRI 
regulation during eye development (and within the CNS) in a near-endogenous 
context. 
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It is important to note that I have analysed variations of proposed eye-specific 
enhancers from the sixth intron of so here. Enhancer activity within the CNS 
of larvae or adults has not been reported and I was interested in clarifying 
whether the enhancers were active within the CNS. I particularly wanted to 
examine the oscillator neurones of the central brain in adults as data is 
emerging that TOY is expressed within these cells and that TOY and SO 
binding sites are present in the Clk locus (Glossop et al., unpublished results). 
In addition, there is an assumption being made here, that extension of the 
enhancer will necessarily reflect endogenous interactions with greater 
accuracy. Furthermore, as I was not able to obtain SO antibody for 
comparison of protein expression to enhancer activity, assessment of 
enhancer activity may be somewhat biased towards it’s coincidence with EYA. 
 
4.3.2.1 GFP expression in larvae 
If VRI is a repressor influencing the so7 enhancer, a transgenic reporter 
containing a larger portion of intron 6, from site s3 up to and including so7 
(so7+VP), would reduce GFP expression in the anterior eye disc and the PE 
and mutating the VRI sites of that construct (to make construct so7+VP[VP-mut]) 
would show a pattern more closely resembling so7. In fact, in eye discs, the 
results showed quite the opposite, so7+VP increased the intensity but did 
show gross changes in the regional expression of GFP, although GFP was 
expressed in additional cells of ocelli precursors. In addition, mutating the VRI 
binding sites resulted in further up-regulation in intensity of GFP signal, yet 
regional expression was not affected. This suggests that the VRI sites in intron 
six do not act as an ‘off switch’ for this enhancer in the suggested regions. 
The increase in GFP intensity between so7+VP and so7+VP[VP-mut] may have 
resulted from a loss of VRI binding and de-repression – suggestive of fine 
tuning of enhancer activity. The persistence of GFP signal in the PE is 
surprising as EYA and SO (Bonini et al., 1993; Serikaku and O’Tousa, 1994) are 
not expressed within that region yet so7 does mediate expression in that 
region. Other variables, either cis-regulatory regions or trans-acting factors, 
must be influencing suppression of SO in the PE. 
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Enhancer activity in brains of L3 larvae showed some characteristics of that 
observed in the eye discs. Reporter expression mediated by so10 was observed 
in the central brain, VNC and the outer optic anlagen. Expression of reporter 
by so7 was observed in all the same regions as with so10 but in many more 
cells; only in the outer optic anlagen of brains of both, so10 and so7 drivers, 
was co-expression with EYA observed. Extension of so7 to so7+VP reduced 
expression of GFP in the VNC and the central brain but increased GFP 
expression in the outer optic anlagen. As seen in eye discs, mutation of the 
VRI sites did not change this expression pattern but intensity of GFP 
expression appeared to have increased. GFP expression in the outer optic 
anlagen appears restricted to a subset of lamina precursors by the so10 driver 
and expanding to additional lamina precursors by the so7 driver (Yasugi et al., 
2008). Cells of the entire outer optic anlagen appear to be expressing GFP 
mediated by the so7+VP and so7+VP[VP-mut] drivers (Yasugi et al., 2008). The 
reduction of GFP reporter in VNC and central brain suggests that so7+VP 
contains regulatory sites that refine expression mediated by this enhancer to 
regions connected to the visual system. In both, eye discs and larval brain, 
observed differences are large between so7 and so7+VP but minimal between 
so7+VP and so7+VP[VP-mut] indicating that the role of VRI at this time within the 
CNS may be for minor adjustment of the so intron six enhancer activity. 
 
4.3.2.2 GFP expression in adult CNS and oscillator cells 
Similarly to the larval CNS, so10 and so7 mediate a scattered distribution of 
GFP reporter within the central brain, with an increased number of cells 
expressing GFP with the so7 driver. With the so7 driver, GFP was also 
observed between the lamina and the optic lobe but could not be localised to 
cells definitively. Neither so10 nor so7 drove GFP in the same cells that 
showed either, CLK- or EYA- IR signals. Expansion of the enhancer to so7+VP 
or so7+VP[VP-mut] down-regulated expression of GFP in the central brain but 
increased expression of GFP in the lamina monopolar cells. As suggested for 
the observations of reporter expression in larval brains, intervening DNA 
sequence between the VRI sites and the so7 enhancer is likely being bound by 
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other regulatory factors that orchestrate the changes observed between so7 
and so7+VP enhancer activity. In addition, absence of GFP in oscillator 
neurones of the brain indicates that the selected regions of the intron are not 
directing expression of so in these cells. If so is expressed in the central brain 
oscillator neurones, other cis-regulatory regions will be mediating this 
expression. 
 
4.3.3 EYA expression within the CNS 
 
4.3.3.1 Endogenous EYA expression in distinct groups of cells 
Within the larval CNS, EYA expression in the outer optic anlagen appears to be 
in the presumptive lamina and neuroepithelium. The lamina precursor cells 
also express DAC and, together, with expression of so suggested by the 
enhancer driver lines, may be an indication that similar regulation to that 
observed in eye discs is taking place (Yasugi et al., 2008). Thus, in addition to 
patterning differentiation of the sensory apparatus of the visual system, so 
appears to also influence the development of the optic lobe (Yasugi et al., 
2008). During embryonic development expression of EYA and so is observed in 
neurogenic regions (Kumar and Moses, 2001c) and it is unsurprising that EYA is 
expressed within the CNS, however, these regions have yet to be described 
and extensive further study is required to reveal their function. 
 
I have shown five distinct clusters of EYA expressing cells in the adult brain, 
only two of these were described by Bonini et al. (1998) who described them 
to be within functional rather than anatomical clusters. As for what the 
function may be has yet to be described. There may be some part played 
within the oscillator neurones – two cells of EYA+ve 1 group (see Figure 4.12) 
also show CLK-IR and appear to be DN2 neurones; one cell of the EYA+ve 2 
group also shows CLK-IR and appears to be one of the large DN3 neurones. 
Shafer et al. (2006) found that the DN3 group consisted of heterogenous cells 
– small and large that also differed in reporter gene expression; these cells 
receive input from the LNs via the PDF receptor (Helfrich-Förster et al., 2007; 
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Im and Taghert, 2010). DN2 cells meanwhile, are not directly responsive to LD 
cycles but are instead synchronised to LD by LNs via PDF signalling (Picot et 
al., 2009). In larvae, the DN2s appear to be the thermocycle response 
integrators of the oscillator neurone network. As to how EYA fits into the 
function of these cells – whether it is within oscillator regulation or not 
requires further study. As we move into a time for finer dissection of 
oscillator neurone interactions at the level of individual group 
communication, EYA provides an additional avenue for investigation. 
 
4.3.3.2 Interference of EYA expression by so7+VP – epistatic 
relationship or insertion position effect? 
A wholly unexpected result was that EYA was up-regulated in many cells of 
the ventral nerve cord and central brain for both transgenic drivers generated 
in this study. Similar observations were made in adult brains – EYA was up-
regulated in tissue from so7+VP compared to so7. It is possible that the 
insertion site 51C has an epistatic relationship to EYA and this is the first 
hypothesis that needs to be tested. Use of two independent sites for insertion 
of the transgene should, ideally, have been used as a control measure 
together with generation of an additional transgenic line of the so7 enhancer 
at the same insertion sites for direct comparison. In the absence of those 
controls, immuno-staining of CNS from a fly line with an insertion of a UAS 
responder (i.e. sequence that is not recognised by endogenous Drosophila 
factors) at site 51C will also reveal whether this phenomenon is a result of the 
insertion locus. Another possibility is the introduction of non-coding RNAs via 
the extended enhancer element. 
 
The nearest characterised gene from the insertion target site used for 
transgenics made in this study, so7+VP and so7+VP[VP-mut], M-Spondin, is 18.9kb 
upstream. This gene had been recovered in an enhancer trap screen for genes 
expressed in PRs that found that promoter-less Gal4 inserted 179bp upstream 
of M-spondin showed GFP and lacZ expression in the R7 PRs, lamina and 
medulla (Mollereau et al., 2000). However, the 51C landing platform used as 
the insertion site for transgenic constructs in this study is 18.9kb from the 
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position identified in the enhancer trap study by Mollereau et al. (2000). 
Although this distance does not preclude it from also acting as an enhancer 
trap of M-Spondin (Levine, 2010), observations of GFP expression mediated by 
so7+VP and so7+VP[VP-mut] as well as the pattern of EYA up-regulation suggest 
that it is not merely an enhancer trap. 
 
Firstly, so7>GFP in larval VNC correlates somewhat with the position of cells 
in which EYA is up-regulated in so7+VP>GFP – GFP expression is lost in those 
cells in the latter and EYA is up-regulated. The implication here being that 
the extended region of the so7+VP driver contains sites for factors that co-
repress eya and so and that an additional third copy of the region (the first 
and second being the endogenous copies on each of the homologous 
chromosomes) is saturating these repressors – preventing their endogenous 
role of down-regulating EYA. Next, similarly, the scattered distribution of GFP 
in adult central brains mediated by so7 appears to be reflected in brains from 
the so7+VP line but in the expression of EYA rather than GFP. In addition, up-
regulation of EYA is observed in cells that do not express M-spondin, namely, 
the ocellar interneurones, the H-B tract and additional compound eye PR 
axons than R7. There is expression within the lamina, which could result 
either from the interference with epistatic relationships proposed here or due 
to some enhancer trap effect of M-spondin. It must be conceded that the 
dramatic increase in EYA is puzzling because, despite the hypothesised 
alterations in gene regulation in trans, increases to such an extent would not 
be expected. Moreover, EYA is distributed through the cytoplasm, thus far 
only nuclear localisation of EYA has been described (Bonini et al., 1993); 
although the aberrant localisation may be attributed to the large amount of 
EYA protein present. However, this interpretation, though intriguing, must be 
regarded with caution pending the results from control experiments using flies 
with a different transgene inserted at site 51C and use of different insertion 
sites for so7+VP. 
 
The gene CG11145 is present on the minus strand within the sixth intron of so 
and is positioned and oriented such that so7+VP is 187bp upstream, the VRI 
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site s3 being proximal. A small gene of three exons spanning only 690bp from 
transcriptional start site to end (including introns), it has yet to be annotated 
with a molecular function or biological process (Tweedie et al., 2009) but one 
annotated transcript has been described from the cDNA library described in 
the second release of the Drosophila Gene Collection (Stapleton et al., 2002). 
As there is no data available at present it is possible that regions adjacent to 
CG11145 in intron six of so regulate this gene which may itself regulate EYA 
expression. 
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Chapter 5 eya and so RNA expression over the 
circadian day 
 
5.1 Introduction 
 
Earlier studies have primarily examined eya and so gene or protein expression 
in embryos or larval eye discs (Kumar and Moses 2001a and 2001b; Markstein 
et al., 2002; Chen et al., 1999; Curtiss and Mlodzik, 2000; Halder et al., 1998; 
Niimi et al., 1999). Bonini et al (1998) show EYA protein is present in cone 
and pigment cells of ommatidia, in medial cells of ocelli and in clusters in the 
CNS. Serikaku and O’Tousa (1994) describe SO immunoreactivity in nuclei for 
the PRs R1-R7, ocelli and in the optic lobe.  
 
A novel technique that can isolate mRNA from specific tissues by transgenic 
expression of an RNA poly-A binding protein (PABP) utilised a rhodopsin-1 
driver line (Yang et al., 2005). PABP was expressed in PRs R1-R6 and isolated 
mRNA was compared to whole head mRNA from wild-type flies. Although this 
method does not define the entire transcriptome of R1-R6, it is likely isolating 
actively expressed transcripts. This approach found that eya and so transcript 
levels were >2-fold compared to whole head. Values were provided for so but 
not eya (listed in supplementary information) and a dataset has been 
assembled for the Affymetrix microarray data series of this experiment (Gene 
Expression Omnibus profile accession number GSE1790, DataSet GDS2479). 
Inspection of the data indicates that the percentile rank for so in whole heads 
is 55-65% and 80-85% within R1-R6. Percentile rank for eya is higher at 70-75% 
in whole head and 90-98% within R1-R6. These data suggest that, in the adult 
head, eya and so transcripts are present PRs R1-R6, and, in the head/ brain of 
flies that lack compound eye PRs and ocelli (i.e. eya mutant). Also indicated 
is that isolation of R1-R6 PABP-bound transcripts, alters the expression level 
rank of eya and so within this trancriptome – raising their profile compared to 
Chapter 5 eya and so RNA expression over the circadian day 
126 
whole head. Importantly, the time of day at which samples were collected is 
not indicated in this study. 
 
The data presented in this chapter, taken together with that by Bonini et al 
(1998), Serikaku and O’Tousa (1994) and Yang et al (2005) all indicate that 
eya and so transcripts and proteins are expressed within the visual system and 
the central brain. Protein expression has also been shown within the visual 
system for both of these genes and, in the case of EYA, is also observed within 
the central brain at four tested time points (Chapter 4). However, as observed 
for CLK expression within circadian neurones, protein is constitutively present 
despite cyclical changes in transcript levels (Glossop et al., 2003; Houl et al., 
2006 and 2008). Photoreceptors form the largest complement of oscillator 
neurones of the adult head (Cheng and Hardin, 1998) and their physiology is 
influenced by circadian and light changes (Barth et al., 2010). In addition, eya 
and so are major upstream determinants of photoreceptors during 
development (reviewed in Kumar, 2009a and 2009b; Jemc and Rebay, 2007a) 
and are present in mature photoreceptors (Bonini et al., 1998; Serikaku and 
O’Tousa, 1994; Yang et al., 2005). Visual system physiology has been shown to 
alter in a circadian manner (Cheng and Hardin, 1998; Barth et al., 2010). For 
this interaction between time of day and physiology, there must be 
communication between the circadian oscillator and the physiological 
programmes of the eye. Thus far correlations are shown between circadian 
disruptions on visual functions but molecular links have yet to be established. 
I hypothesise that circadian factors interact with upstream PR determinants, 
e.g. eya and so, to influence changes in physiology. As yet, a time course of 
eya and so expression has not been described. 
 
I was interested in examining eya and so transcript localisation within whole 
heads and, in addition, whether there were photo-dependent and/ or 
circadian-regulated changes in transcript expression within and between 
different regions. Using anti-sense RNA probes directed against eya and so, I 
show here preliminary qualitative analyses that reveal that both transcripts 
are localised to similar regions of the visual system and central brain. 
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Furthermore, by comparing head sections from flies collected every 4hrs 
across a 12:12 L:D cycle, it is evident that eya and so mRNA levels are not 
constitutively expressed in the brain or compound eye. For eya, transcripts 
are clearly visible during the early light phase (ZT2, 6) but decline to low/ 
undetectable levels at the end of the light phase and early dark phase (ZT10, 
14) before rising in the mid-late dark phase (ZT18, 22). For so, transcript 
levels are high throughout the light phase and early dark phase (ZT2, 6, 10, 
14) but decline to low/ undetectable levels in the mid-late dark phase (ZT18, 
22). Hence, eya and so expression are both rhythmic but they show different 
phasing in the time at which trough levels are reached. Similar results were 
observed in oscillator-deficient cyc01 mutant fly heads. This indicates that the 
expression of eya and so is regulated, at least in part, via a circadian-
independent mechanism and, hence, predominantly by photoperiod. 
However, in the cyc01 mutant, the intensity of signal of both, eya and so, was 
elevated in the visual system, suggesting that the presence of a functional 
circadian mechanism may be necessary to dampen peak levels of expression in 
the PRs. Together, the results of this chapter suggest that eya and so 
expression in the oscillator (PRs) and non-oscillator (central brain) cells in the 
adult are predominantly regulated by photoperiod, but in oscillator cells the 
circadian mechanism may modulate this expression by damping the peak 
expression of both genes. 
 
5.2 Results 
 
Immunological staining of larval and adult CNS reveals that EYA protein is 
expressed in several cell clusters. An enhancer element from intron 6 of so, 
and expansions thereof developed in this study, did not mediate reporter 
gene expression in the same cell clusters as EYA within the CNS. Here, I show 
in situ hybridisation against the eya and so mRNA transcripts in whole adult 
head in wild type and oscillator deficient cyc01 mutants over a 24-hour period. 
 
Frontal brain sections were applied to slides sequentially to ensure that all 
samples within a genotype and time of day cohort are from the same set of 
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animals across the set of RNA probes used. Sense probes did not hybridise at 
any time point in either genotype. On wild type adult heads, anti-sense 
probes for eya and so both hybridised to similar regions of the brain (Figures 
5.1-6, images shown here are sections between the ocelli and proboscis along 
the antero-posterior axis). Signal was seen in (1) components of the visual 
system: PRs R1-R7, R8 and/ or lamina, lateral medulla and the ocellar region. 
(2) Within the central brain: dorsal superior protocerebrum, dorso-lateral and 
ventro-lateral regions. In more posterior sections, staining appeared to 
encircle the mushroom bodies and extend to the midline. Changes were 
observed in hybridisation over the course of the day and were synchronous 
between the visual system and central brain signals but the two different 
genes showed different phases. Hybridisation of eya probes was seen at ZT2, 
6, 18 and 22 but reduced to background levels during ZT10 and 14. 
Hybridisation of so probes was high during ZT2, 6, 10 and 14 and reduced to 
background levels at ZT18 and 22. 
 
It was predicted that any rhythms in eya and so transcript levels must be 
driven, either, by the light-dark cycle, or by the circadian clock. To 
distinguish between these possible mechanisms, eya and so transcripts were 
monitored in the oscillator-deficient cyc01 mutant background. Generally, the 
same expression trend observed in wild type head sections persists in cyc01 
head sections – similar visual system and central brain regions show probe 
hybridisation; and the down-regulation of eya at ZT10 and 14 (compare 
Figures 5.3, 5.4), and so at ZT18 and 22 is maintained (compare Figures 5.5 
and 5.6 ). Preservation of the signals observed in control flies indicates that 
the oscillator is not necessary for regulating rhythmic expression of these two 
genes. However, hybridisation signal intensity is higher in the visual system of 
cyc01 head sections indicating that, in the presence of a functioning oscillator, 
eya and so transcript levels appear to be dampened. 
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Figure 5.1 w and cyc01 fly heads hybridised with eya and so probes at ZT2. n=10 each, male and female. 
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Figure 5.2 w and cyc01 fly heads hybridised with eya and so probes at ZT6. n=10 each, male and female. 
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Figure 5.3 w and cyc01 fly heads hybridised with eya and so probes at ZT10. n=10 each, male and female. 
Chapter 5 eya and so RNA expression over the circadian day 
132 
Figure 5.4 w and cyc01 fly heads hybridised with eya and so probes at ZT14. n=10 each, male and female. 
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Figure 5.5 w and cyc01 fly heads hybridised with eya and so probes at ZT18. n=10 each, male and female. 
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Figure 5.6 w and cyc01 fly heads hybridised with eya and so probes at ZT22. n=10 each, male and female. 
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5.3 Discussion 
 
5.3.1 eya and so are expressed in the visual system and central 
brain 
 
Hybridisation of full length anti-sense probes of eya and so seen here support 
indications that eya and so are enriched in PRs R1-R6 (Yang et al., 2005). 
Although preliminary and qualitative rather than quantitative, these data do 
indicate that there are changes in expression profile over a 24-hour period 
within the central brain and visual system tissues. In addition, the gross 
spatial pattern of expression for eya and so is similar, but the phase of 
expression differs. As the same expression trend was observed in wild type 
and circadian rhythm defective strains, it is unlikely that the circadian 
oscillator mechanism mediates these changes. However, hybridisation signal 
intensity appears to be higher in the visual system (i.e. PR oscillator cells) of 
the cyc01 mutant. It is possible that although the oscillator does not control 
spatial expression of these genes, a normal function of the oscillator is to 
dampen expression levels – i.e. a regulation that is absent in the cyc01 mutant. 
VRI expression is reduced in cyc01 flies and it would be possible to determine 
whether VRI is the modulator here by over-expressing VRI in cyc01 mutants. 
 
Collection of heads for sectioning was, by necessity, carried out for a short 
time in the light. Clearly, this means that flies collected during the dark 
phase had some light exposure prior to being frozen for further processing. 
Despite attempts to minimise the duration of these light pulses for dark phase 
flies, as the kinetics of gene transcription here are unknown, it is possible 
that the reduction in so transcription at ZT18 and 22 is due to an acute 
clearance of so mRNA in response to light. If this is the case, light-mediated 
clearance mechanisms can only operate in the mid-late night as transcript 
levels are not affected at ZT14. The reduction in eya probe hybridisation at 
ZT10 and 14 is likely to be an endogenous mechanism of clearance of 
transcript or down-regulation of transcription; possibly as a result of 
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photoperiod or an acute response timed to either, lights-on or lights-off. 
However, without further paradigms, it is possible that the up-regulation of 
eya observed at ZT18 and 22 is due to light pulse activation. Again, if this is 
the case, up-regulation of eya in response to light is only responsive in mid-
late night phase. 
 
5.3.2 Functional significance of observed hybridisation signals 
 
To date, functions of EYA and SO in relation to one another for downstream 
regulation have been most extensively studied. Less well-represented are 
other functional partners of the two. It is known that SO can partner with 
GROUCHO and that EYA can form a complex with DAC alone or together with 
SO. In terms of transcription factor activity, SO contains the DNA binding 
domain but does not contain nuclear localisation signals and, therefore, 
requires a protein partner that confers this function. EYA on the other hand, 
does not have a DNA binding domain but provides the transactivation function 
and is also a protein tyrosine phosphatase. Transactivation function appears 
to require phosphatase activity on a target-dependent basis, moreover, 
phosphatase activity may be required in the cytoplasm as well as the nucleus. 
Given this information about protein domains and functions, what continues 
to be uncertain is how early experiments charting ectopic eye development 
by mis-expression of these proteins, individually, were successful. Certainly, 
co-expression of EYA and SO in other imaginal discs is synergistic in ectopic 
eye formation and resulted in a greater percentage of ectopic organs. 
However, that eye formation proceeded in the absence of one of the 
partners, suggests that other factors are also able to supplement the 
complementary functions that EYA and SO require of one another. These 
unknown aspects may be more or less relevant for the roles of EYA and SO 
within the developed visual system and CNS. 
 
Based on the expression patterns observed here, it is possible that EYA and SO 
function as a complex as expression seems to be in similar regions. Further 
tissue resolution and protein co-incidence confirmation is required as are 
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studies into the co-incidence of other dimerisation partners of these two 
proteins. Of particular interest is whether GROUCHO is involved as it partners 
with SO and is a transcriptional repressor – as SO provides the DNA recognition 
domain, there is potential for antagonism of the transcriptional output of 
EYA-SO if expression is coincident. Furthermore, provided the hybridisation 
signals observed were not artefacts (as mentioned above), spatial and 
temporal modulations of output are possible. The sketch in Figure 5.7 shows 
that eya and so may be co-expressed during the early-mid day; after this eya 
is down-regulated but so persists at high levels; this is followed by a fall in so 
expression as eya rises. eya expression seems to follow a similar phase to that 
of Clk mRNA but does rise whilst VRI is still close to peak levels. Whereas so 
hybridisation signals appear to be high whilst VRI protein levels increase and 
only fall after VRI reaches peak levels. This is certainly possible if VRI were to 
be modulating transcription of so rather than acting as a primary regulator. Of 
course, this is speculative and several supportive analyses remain to be 
carried out to verify the rhythm in expression and quantify it. 
 
 
Figure 5.7 Sketch of genes and proteins in whole head. Curves for VRI protein and Clk 
mRNA have been sketched from Glossop et al (2003) and superimposed on a sketch of eya and 
so transcript levels as qualitatively determined in this study. 
 
Studies in Japanese quail, sheep and mouse indicate that expression of one of 
the four vertebrate homologues of EYA, Eya3, is regulated by and engages in a 
photoperiodic response. In sheep, Eya3 peak expression occurred 12hrs after 
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lights-off within the pars tuberalis – an anterior region of the pituitary gland 
that receives circadian input and mediates seasonal response. In mice models, 
Eya3 expression followed somewhat altered kinetics but long photoperiod 
conditions resulted in an early morning peak in expression. These kinetics 
mean that on short photoperiod days of 8:16 LD, Eya3 peak was during the 
dark phase (in sheep, unconfirmed in mice). On long photoperiod days of 16:8 
LD, levels were at peak during the light phase in sheep and mice; and in the 
late day in quail. Regardless of the exact timing of the peak in Eya3 
expression, in all three models, in vitro reporter assays of the thyrotrophin! 
promotor revealed synergistic activation by co-expression of Eya3 and Six1 
(one of the six vertebrate so family homologues). Thyrotrophin regulates a 
physiological response to seasons and these data suggest that Eya3-Six1 (and 
other factors) lie upstream of this regulation. Interactions between Eya3-Six1, 
thyrotrophin and the oscillator mechanism have not been placed within a 
model framework as yet. Although, it does place Eya3-Six1 within the overall 
circadian physiological mechanism. 
 
If eya expression in Drosophila follows a similar mechanism to that observed 
for Eya3, the night-time expression at ZT18 and 22 observed here may simply 
be an acute light activation that is only responsive during the mid-late night 
and was stimulated by exposure of animals to light during collection. 
Alternatively, eya expression kinetics may be different to that observed in 
vertebrates and peak expression of eya in flies is during the mid-dark phase, 
different photoperiods may change this expression to be coincident with so 
and regulate a seasonal response. 
 
One of the seasonal phenotypes affected by photoperiod is that of 
reproductive state. In Drosophila, short photoperiods coupled with low 
temperature lead to reproductive and developmental dormancy, or diapause. 
At present there is insufficient evidence of the influences of the circadian 
clock on diapause, either directly and/ or via interactions with 
photoperiodism and hormonal changes. eya is also expressed within 
Drosophila ovaries and, if expression in the ovaries changes over the LD cycle 
Chapter 5 eya and so RNA expression over the circadian day 
139 
as observed here in the CNS, may be tracking photoperiod to initiate 
diapause. Alternatively, photoperiodic tracking within the CNS may interact 
with the endocrine system to signal to the ovaries to enter diapause. 
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Chapter 6 General discussion 
 
6.1 Summary of the current study 
 
I have described here initial molecular links between the developmental 
factors VRI, EYA and SO. Interactions within the eye disc were used as a 
starting point as the correct expression of all three factors is critical during 
PR differentiation (George and Terracol, 1997; Szuplewski et al., 2003; 
reviewed by Kumar, 2009). During early larval growth, a time when cells of 
the imaginal discs proliferate, VRI is expressed within several imaginal discs 
including, the pertinent tissue here, the eye disc. As expected, the presence 
of VRI within the eye disc was not dependent on CLK-CYC, the circadian 
activator of vri (Glossop et al., 2003). I also found that PDP1 protein, of which 
the ! isoform also binds to VRI sites (Cyran et al., 2003), does not appear to 
be expressed within the eye disc. 
 
As PR differentiation begins, down-regulation of VRI prior to MF advancement 
is apparent (Figures 3.2, 3.5). However, initial PR differentiation and 
ommatidial cluster formation appeared to be unaffected when VRI expression 
was maintained in the developing neurones (Figures 3.9, 3.10). However, 
there were differences between cells comprising the developing PR 
epithelium (Figure 3.10). Endogenous down-regulation of VRI appears to be 
necessary for the survival of the developed ommatidia since vri expression in 
newly differentiated PRs causes defects during pupal eye maturation and, 
ultimately, leads to death as pharate adults (Figures 3.12, 3.13). Developing 
eyes begin to necrose during pupal stages and it is likely that the 
inflammatory responses to necrosis (Kroemer et al., 1998) result in lethality 
(Figures 3.12, 3.13). 
 
These results are indicative of a role for VRI that I propose to follow two 
paths simultaneously; (1) developmental regulation – here targets of VRI 
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regulation are proposed to be of a more generalised nature, for example, as 
put forward previously, of cytoskeletal regulation (Szuplewski et al., 2003) or 
cell proliferation (Gauhar et al., 2009). (2) tissue-specific modulation – here 
targets of VRI are proposed to be a part of the patterning events of a given 
tissue. In this case, eya and so in the eye disc, are responsive to attenuation 
by VRI and it remains to be seen whether VRI affects other eye-specific 
factors, either as an attenuator or as a more dominant modulator (Chapter 3). 
 
To further explore a functional relationship between vri, eya and so, the 
presence of several putative VRI target sites in eya and so genomic loci were 
confirmed in vitro (Figure 4.1, Table 4.1). The proximity of two of the 
indentified sites in the so locus to an identified enhancer of so located in the 
sixth intron (Niimi et al., 1999; Punzo et al., 2002; Pauli et al., 2005) might 
suggest that multiple factors bind intron six to co-ordinate expression of so. I 
have generated novel transgenic animals to determine the contribution of the 
VRI sites in the intron in regulation of the enhancer (Figure 4.2). 
 
Two variants of the enhancer from the original studies were used for 
comparison that were 0.4kb (so10) and 1.6kb (so7) in size and so7 was 
modified to contain an additional 2.3kb region of the intron (so7+VP). As it is 
likely that other transcription factor binding sites are present within the 
additional 2.3kb, the specific contribution of the VRI sites was determined by 
generation of a second transgenic line in which the VRI sites were specifically 
mutated (so7+VP[VP-mut]). GFP reporter expression mediated by these 
enhancers was examined in several different tissues. Within all tissues, 
differences between so7+VP and so7+VP[VP-mut] were seen in the signal 
intensity of the reporter rather than localisation of reporter, higher signal 
intensity being observed with so7+VP[VP-mut] (Figures 4.5, 4.6, 4.7, 4.10, 4.15, 
4.16). An increase in reporter expression, presumably due to ablation of the 
VRI sites, supports a negative modulatory role for VRI at the so locus (as 
indicated by Chapter 3). 
 
Chapter 6 General discussion 
142 
Comparison of so7 and so7+VP within larval and adult CNS shows that 
extension of the enhancer restricts reporter expression to cells of the visual 
system – outer optic anlagen of larvae and the lamina of adult brains (Figures 
4.9C, 4.10A, 4.14, 4.15). Expression observed within the central brain with 
so7 is not seen with so7+VP. This is not necessarily an accurate reflection of 
so expression – it is possible that regions of intron six of so drive expression of 
so relevant to the visual system and that an alternative enhancer directs 
central brain expression. This is supported by so transcript expression 
described in Chapter 5 where probes directed against so hybridised to regions 
of the central brain as well as the visual system (Figures 5.1-5.6). The 
transcript expression in the central brain is not reflected by any of the intron 
six transgenic reporters (Figures 4.13-4.16). The so1 mutant has a deletion of 
the so7 enhancer and only shows visual system phenotypes (Heitzler et al., 
1993; Serikaku and O’Tousa, 1994; Cheyette et al., 1994; Punzo et al., 2002). 
However, lethal phenotypes are observed for other mutants of so. Lethality 
from certain alleles likely results from developmental lesions in neurogenic 
regions during embryonic development (Kumar, 2001b). Thus far, only 
embryonic and eye disc development expression of so has been described 
(Kumar, 2009b) yet it is likely, as seen for EYA, that so is expressed within the 
central brain. Hence, these enhancers are incomplete descriptors of 
endogenous so expression but do highlight interesting aspects of so regulation 
within the visual system, particularly the apparent effect on EYA expression 
(discussed further below). 
 
Changes in EYA protein levels observed in the CNS of L3 and adults containing 
the so7+VP and so7+VP[VP-mut] transgenes may indicate that the additional 
2.3kb of the intron contains a region that indirectly interferes with eya 
regulation (Phillips, 1998). Initial indications were that insertion of an 
additional copy of this 3.9kb region of so intron six leads to an up-regulation 
of eya expression because regulatory factors that bind to this region appear to 
be suppressors of so expression within the CNS and may also suppress eya 
expression. Insertion of an additional copy of the so7+VP region, creating 
three copies within the genome, may have a saturating effect that relieves 
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this repression on eya, enabling dominance by activators (Chapter 4). 
However, the dramatic observed increases in eya expression implicate the 
genetic background and positional effect variegation rather than the 
transgene itself. Non-coding RNAs from the insertion site used for the 
transgene have not been described as yet but may be a likely influence. In 
addition, the expression domain of the transgene has not been exhaustively 
studied and ectopic effects may alter eya expression via other routes. 
 
Gene or protein expression within the adult CNS for eya or so has not been a 
focus thus far and only been described in brief (Serikaku and O’Tousa, 1994; 
Bonini et al., 1998; Yang et al., 2005). Neither have they been explored 
within the field of circadian biology in Drosophila, although recent data from 
Japanese quail, mouse and sheep, that implicate EYA homologues to be part 
of a pituitary photoperiodic response, may also be relevant to flies (Nakao et 
al., 2008; Masumoto et al., 2010; Dardente et al., 2010). EYA protein was 
observed in the DN2s and one of the large DN3 neurones in adult brains but a 
rhythm in protein expression was not seen (Figure 4.12). This, in itself, does 
not exclude EYA from circadian regulation as CLK protein does not show 
rhythmic expression in the oscillator neurones either (Houl et al., 2008). 
Sectioned adult heads were examined for eya and so transcripts at 4hr 
intervals over an LD cycle in wild-type and oscillator-deficient animals. 
Rhythmic levels of mRNA were observed but the phase was different for eya 
and so (Figures 5.1-5.6). Furthermore, eya and so transcripts were detected in 
the visual system and the central brain with somewhat altered levels between 
the wild-type and oscillator-deficient cohorts. Therefore, it appears that 
although eya and so show rhythmic expression, this is not mediated by the 
classical molecular oscillator mechanism. Expression appears to be linked to 
photoperiod but the oscillator may attenuate this expression as higher levels 
of hybridised probe were observed in heads of animals lacking an oscillator. 
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6.2 Conclusions 
 
During eye development, it appears that VRI attenuates expression of eya and 
so. However, it is likely that this is a secondary function of VRI expression in 
the eye disc. Given the necessity of VRI during embryonic development 
(George and Terracol, 1997) and the expression of VRI in other imaginal 
tissues (Szuplewski et al., 2003), together with the current study, indicate a 
function as part of developmental pathways that are common to the imaginal 
tissues. Expression of EYA within a small subset of oscillator neurones and 
changes in transcript levels of eya and so within the PRs suggest that these 
two eye development factors may interact with the oscillator. However, this 
is likely to be upstream of the oscillator as changes in transcript levels persist 
in oscillator-deficient mutant flies. Taken in conjunction with data from 
Gummadova et al., (2009) and Glossop et al., (unpublished results), a model 
of interactions between the eye development and oscillator factors is 
depicted in Figure 6.1. 
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Figure 6.1 Model of interactions between eye development and oscillator factors. (A) 
Interactions occurring within the developing PRs. (B) Interactions occurring within mature PRs 
and/ or central oscillator neurones. Solid arrows depict known pathways, dashed arrows 
depict hypothesised interactions. 
6.3 Future directions 
 
A role for VRI in attenuation of eya and so gene expression is suggested here 
during eye development (Figure 4.6) and within mature PRs (Figures 5.1-5.6) 
that are themselves also oscillators (Siwicki et al., 1988; Zerr et al., 1990; 
Cheng et al., 1998; Meinertzhagen and Pyza, 1999; Barth et al., 2010). Three 
main proposals for further study are outlined below and their relevance is 
discussed in the following section. 
 
• To determine the targets of VRI regulation within the eye disc, a 
chromatin immuno-precipitation (ChIP) assay would be most useful. In 
order to define the cis-acting targets of VRI in the eye disc alone, eye discs 
collected from over 100 larvae would be required to provide enough DNA 
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for the procedure. Once the targets of VRI regulation specifically within 
the eye disc are known, we can begin to answer the questions of whether 
VRI can be classified as one of the eye DR or as an RDGN factor. 
• Gene and protein expression profiles of eya and so under different 
photoperiodic conditions should be the next step to expand upon the 
preliminary results discussed here. In addition it will complement recent 
findings in vertebrates that Eya and Six homologues transmit photoperiod 
information to the pituitary endocrine system (Nakao et al., 2008; 
Masumoto et al., 2010; Dardente et al., 2010) as well as emerging data on 
Clk regulation by eye development factors (Glossop et al., unpublished 
results). 
• Following expression profiling, it is necessary to pinpoint the actual 
targets of EYA and SO. To fully grasp their influence in developmental and 
photoperiodic pathways, functional description of EYA and SO is now 
necessary. 
 
6.4 Perspectives and outlook 
 
The circadian oscillator mechanism is described as an interlocked feedback 
loop model that is self-sustaining. The effect of these feedback loops is 
monitored in two ways, (1) as cyclical changes in gene and protein expression 
of the factors comprising the mechanism requiring approximately 24hrs. And, 
(2) physiology of the organism that is adaptive to the challenges and 
requirements that the organism encounters in relation to the light-dark cycle. 
External inputs to the oscillator mechanism are indicated by isolation of novel 
enhancers in the Clk gene that do not contain binding sites for the only known 
activator of Clk at present (Cyran et al., 2003; Gummadova et al., 2009). 
Furthermore, early indications are that the eye development regulator TOY 
acts via direct and indirect mechanisms on these novel enhancers (Glossop et 
al., unpublished results).  
 
It must be noted that the popularity of Drosophila as a research model is due 
to a high degree of homology with vertebrate genes. vri, eya, so, toy and Clk 
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are all conserved within vertebrates. The congenital disorders that result 
from disruption of eya, so and Pax-6 together with other diseases, notably 
cancer, that can result from disruptions of eya, so and the oscillator, 
necessitate their study. 
 
Study of the developing eye disc and circadian rhythms are each somewhat of 
a double-edged sword. On one side, data on molecular regulatory interactions 
between transcriptional networks orchestrating the mechanisms is plentiful 
and we can describe exquisite details of these systems. Conversely, these 
data have revealed several levels of feedback regulation between networks 
and individual factors such that mapping these interactions makes for an 
intricate genetic network. Mathematical modelling approaches for depicting 
these interactions has already begun in order to plot eye development events 
(Graham et al., 2010) and oscillator maintenance (Fromentin et al., 2010). As 
we progress, a dual approach incorporating both, molecular biology 
techniques and mathematical simulations, will be required as each will be 
required to complement and inform the other. 
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